Christopher Kane

Title(s)Professor, Urology
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Overview 
    Collapse Overview
    Dr. Christopher J. Kane is a specialist in prostate cancer and an expert in robotic and other minimally invasive procedures for urologic surgery.

    Named a 2017 “Top Doc" in San Diego Magazine’s “Physicians of Exceptional Excellence" annual survey performed in collaboration with the San Diego County Medical Society, Dr. Kane is internationally recognized for his patient care and research in prostate cancer, renal cell carcinoma, and minimally invasive surgical treatment of urologic diseases and disorders.

    Dr. Kane is an expert in robotic prostatectomy, open and laparoscopic kidney cancer surgery and bladder and testes cancer surgery. He has authored more than 220 publications and book chapters primarily on prostate cancer risk factors and outcomes, prostate cancer surgery and minimally invasive surgery for prostate and kidney cancer. He has taught laparoscopy and robotic surgery extensively and started the robotic surgery program at UC San Francisco and at the VA Medical Center San Francisco in 2002.

    He performs over 200 robotic cancer surgeries per year and is highly experienced in nerve sparing robotic prostatectomies, robotic radical cystectomy for bladder cancer and robotic partial nephrectomy for kidney cancer.

    To make an appointment with Dr. Kane, please call: 858-822-6187

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Addressing racial disparities in prostate cancer pathology prediction models: external validation and comparison of four models of pathological outcome prediction before radical prostatectomy in the multiethnic SEARCH cohort. Prostate Cancer Prostatic Dis. 2024 Apr 11. Mottaghi M, Gu L, Deivasigamani S, Adams ES, Parrish J, Amling CL, Aronson WJ, Kane CJ, Terris MK, Guerrios-Rivera L, Cooperberg MR, Klaassen Z, Freedland SJ, Polascik TJ. PMID: 38605270.
      View in: PubMed   Mentions:
    2. Contemporary risk of biochemical recurrence after radical prostatectomy in the active surveillance era. Urol Oncol. 2024 Mar 14. Das S, Luu M, Terris M, Klaassen Z, Kane CJ, Amling C, Cooperberg M, Rivera LG, Aronson W, Freedland SJ, Daskivich TJ. PMID: 38490923.
      View in: PubMed   Mentions:    Fields:    
    3. Do Hispanic Puerto Rican men have worse outcomes after radical prostatectomy? Results from SEARCH. Cancer Med. 2024 Feb; 13(4):e7012. Guerrios-Rivera L, Janes JL, De Hoedt AM, Klaassen Z, Terris MK, Cooperberg MR, Amling CL, Kane CJ, Aronson WJ, Fowke JH, Freedland SJ. PMID: 38457188; PMCID: PMC10922022.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    4. A Multicentric, Retrospective, Real-world Study on Immune-related Adverse Events in Patients with Advanced Non-small Cell Lung Cancers Treated with Pembrolizumab Monotherapy. Clin Oncol (R Coll Radiol). 2024 Mar; 36(3):193-199. Lerner A, Lee AJX, Yan H, Van Griethuysen J, Bartlett AD, Veli M, Jiang Y, Luong M, Naban N, Kane C, Conibear J, Papadatos-Pastos D, Ahmad T, Chao D, Anand G, Asghar US. PMID: 38246850.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. Postradical prostatectomy prostate-specific antigen outcomes after 6 versus 18 months of perioperative androgen-deprivation therapy in men with localized, unfavorable intermediate-risk or high-risk prostate cancer: Results of part 2 of a randomized phase 2 trial. Cancer. 2024 Jan 01. McKay RR, Xie W, Yang X, Acosta A, Rathkopf D, Laudone VP, Bubley GJ, Einstein DJ, Chang P, Wagner AA, Kane CJ, Preston MA, Kilbridge K, Chang SL, Choudhury AD, Pomerantz MM, Trinh QD, Kibel AS, Taplin ME. PMID: 38161319.
      View in: PubMed   Mentions:    Fields:    
    6. Diabetes and Prostate Cancer Outcomes in Men with Nonmetastatic Castration-Resistant Prostate Cancer: Results from the SEARCH Cohort. Cancer Epidemiol Biomarkers Prev. 2023 09 01; 32(9):1208-1216. Sergeyev A, Gu L, De Hoedt AM, Amling CL, Aronson WJ, Cooperberg MR, Kane CJ, Klaassen Z, Terris MK, Guerrios-Rivera L, Freedland SJ, Csizmadi I. PMID: 37294698; PMCID: PMC10529387.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. The state of focal therapy in the treatment of prostate cancer: the university of California collaborative (UC-Squared) consensus statement. Prostate Cancer Prostatic Dis. 2023 Aug 08. Javier-DesLoges J, Dall'Era MA, Brisbane W, Chamie K, Washington SL, Chandrasekar T, Marks LS, Nguyen H, Daneshvar M, Gin G, Kane CJ, Bagrodia A, Cooperberg MR. PMID: 37553435.
      View in: PubMed   Mentions:    Fields:    
    8. Editorial Comment. J Urol. 2023 10; 210(4):637-638. Javier-DesLoges J, Bagrodia A, Crawford ED, Kane CJ. PMID: 37527395.
      View in: PubMed   Mentions:    Fields:    
    9. Are associations between obesity and prostate cancer outcomes following radical prostatectomy the same in smokers and non-smokers? Results from the SEARCH Cohort. Cancer Causes Control. 2023 Nov; 34(11):983-993. Liu IT, Gu L, De Hoedt AM, Cooperberg MR, Amling CL, Kane CJ, Klaassen Z, Terris MK, Guerrios-Rivera L, Vidal AC, Aronson WJ, Freedland SJ, Csizmadi I. PMID: 37405681.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. Time from biopsy to radical prostatectomy by race in an equal-access healthcare system: Results from the SEARCH cohort. Prostate. 2023 Aug; 83(11):1011-1019. Pereira V, Oyekunle T, Janes J, Amling CJ, Aronson WJ, Cooperberg MR, Kane CJ, Terris MK, Klaassen Z, Freedland SJ, Vidal AC, Csizmadi I. PMID: 37096737.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    11. A modeling study to estimate prostate cancer-specific mortality on active surveillance for men with favorable intermediate-risk prostate cancer: Results from the SEARCH cohort. Cancer Med. 2023 05; 12(9):10931-10938. Kuhlmann PK, Oyekunle T, Klaassen Z, Amling CL, Aronson WJ, Cooperberg MR, Kane CJ, Terris MK, Freedland SJ. PMID: 37031461; PMCID: PMC10225172.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    12. Prognostic Value of the Intermediate-risk Feature in Men with Favorable Intermediate-risk Prostate Cancer: Implications for Active Surveillance. Eur Urol Open Sci. 2023 Apr; 50:61-67. Sherer MV, Leonard AJ, Nelson TJ, Courtney PT, Guram K, Rodrigues De Moraes G, Javier-Desloges J, Kane C, McKay RR, Rose BS, Bagrodia A. PMID: 37101776; PMCID: PMC10123417.
      View in: PubMed   Mentions: 1  
    13. Automated Patient-level Prostate Cancer Detection with Quantitative Diffusion Magnetic Resonance Imaging. Eur Urol Open Sci. 2023 Jan; 47:20-28. Zhong AY, Digma LA, Hussain T, Feng CH, Conlin CC, Tye K, Lui AJ, Andreassen MMS, Rodríguez-Soto AE, Karunamuni R, Kuperman J, Kane CJ, Rakow-Penner R, Hahn ME, Dale AM, Seibert TM. PMID: 36601040; PMCID: PMC9806706.
      View in: PubMed   Mentions: 3  
    14. Integrins Increase Sarcoplasmic Reticulum Activity for Excitation-Contraction Coupling in Human Stem Cell-Derived Cardiomyocytes. Int J Mol Sci. 2022 Sep 19; 23(18). Wang BX, Kane C, Nicastro L, King O, Kit-Anan W, Downing B, Deidda G, Couch LS, Pinali C, Mitraki A, MacLeod KT, Terracciano CM. PMID: 36142853; PMCID: PMC9504605.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    15. Is time to castration resistant prostate cancer a potential intermediate end-point for time to metastasis among men initiating androgen deprivation therapy for non-metastatic prostate cancer with rapid PSA doubling time (<9 months)? Prostate Cancer Prostatic Dis. 2023 03; 26(1):151-155. Klaassen Z, Howard L, Wallis CJD, Janes JL, De Hoedt A, Aronson WJ, Polascik TJ, Amling CJ, Kane CJ, Cooperberg MR, Terris MK, Wu Y, Freedland SJ. PMID: 36050455.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    16. Reply by Authors. Urol Pract. 2022 Sep; 9(5):413. Taich L, Zhao H, Stock SR, Howard LE, De Hoedt AM, Terris MK, Amling CL, Kane CJ, Cooperberg MR, Aronson WJ, Klaassen Z, Polascik TJ, Vidal AC, Freedland SJ. PMID: 37145765.
      View in: PubMed   Mentions:
    17. Radium-223 Utilization Patterns and Outcomes in Clinical Practice. Urol Pract. 2022 Sep; 9(5):405-413. Taich L, Zhao H, Stock SR, Howard LE, De Hoedt AM, Terris MK, Amling CL, Kane CJ, Cooperberg MR, Aronson WJ, Klaassen Z, Polascik TJ, Vidal AC, Freedland SJ. PMID: 37145712.
      View in: PubMed   Mentions:
    18. Validation of the prostate cancer comorbidity index in predicting cause-specific mortality in men undergoing radical prostatectomy. Prostate Cancer Prostatic Dis. 2023 Dec; 26(4):715-721. Chen MS, Howard LE, Stock S, Dolgner A, Freedland SJ, Aronson W, Terris M, Klaassen Z, Kane C, Amling C, Cooperberg M, Daskivich TJ. PMID: 35668181.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    19. Tele-Untethered: Telemedicine Without Waiting Rooms. Qual Manag Health Care. 2023 Apr-Jun 01; 32(2):81-86. Meyer BC, Perrinez ES, Payne K, Carreño S, Partridge B, Braunlich B, Tangney J, Sylwestrzak M, Kremer B, Kane CJ, Longhurst CA. PMID: 35622438; PMCID: PMC10032367.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    20. Clinically Localized Prostate Cancer: AUA/ASTRO Guideline. Part III: Principles of Radiation and Future Directions. J Urol. 2022 07; 208(1):26-33. Eastham JA, Auffenberg GB, Barocas DA, Chou R, Crispino T, Davis JW, Eggener S, Horwitz EM, Kane CJ, Kirkby E, Lin DW, McBride SM, Morgans AK, Pierorazio PM, Rodrigues G, Wong WW, Boorjian SA. PMID: 35536141.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    21. Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part I: Introduction, Risk Assessment, Staging, and Risk-Based Management. J Urol. 2022 07; 208(1):10-18. Eastham JA, Auffenberg GB, Barocas DA, Chou R, Crispino T, Davis JW, Eggener S, Horwitz EM, Kane CJ, Kirkby E, Lin DW, McBride SM, Morgans AK, Pierorazio PM, Rodrigues G, Wong WW, Boorjian SA. PMID: 35536144.
      View in: PubMed   Mentions: 64     Fields:    Translation:Humans
    22. Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part II: Principles of Active Surveillance, Principles of Surgery, and Follow-Up. J Urol. 2022 07; 208(1):19-25. Eastham JA, Auffenberg GB, Barocas DA, Chou R, Crispino T, Davis JW, Eggener S, Horwitz EM, Kane CJ, Kirkby E, Lin DW, McBride SM, Morgans AK, Pierorazio PM, Rodrigues G, Wong WW, Boorjian SA. PMID: 35536148.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    23. Novel Dormancy Mechanism of Castration Resistance in Bone Metastatic Prostate Cancer Organoids. Int J Mol Sci. 2022 Mar 16; 23(6). Lee S, Mendoza TR, Burner DN, Muldong MT, Wu CCN, Arreola-Villanueva C, Zuniga A, Greenburg O, Zhu WY, Murtadha J, Koutouan E, Pineda N, Pham H, Kang SG, Kim HT, Pineda G, Lennon KM, Cacalano NA, Jamieson CHM, Kane CJ, Kulidjian AA, Gaasterland T, Jamieson CAM. PMID: 35328625; PMCID: PMC8952299.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    24. Red Blood Cell Distribution Width Is Associated with All-cause Mortality but Not Adverse Cancer-specific Outcomes in Men with Clinically Localized Prostate Cancer Treated with Radical Prostatectomy: Findings Based on a Multicenter Shared Equal Access Regional Cancer Hospital Registry. Eur Urol Open Sci. 2022 Mar; 37:106-112. Orabi H, Howard L, Amling CL, Aronson WJ, Cooperberg MR, Kane CJ, Terris MK, Klaassen Z, Janes JL, Freedland SJ, Polascik TJ. PMID: 35243395; PMCID: PMC8883186.
      View in: PubMed   Mentions: 3  
    25. Impact of age on treatment response in men with prostate cancer treated with radiotherapy. BJUI Compass. 2022 May; 3(3):243-250. Bryant AK, Nelson TJ, McKay RR, Kader AK, Parsons JK, Einck JP, Kane CJ, Sandhu AP, Mundt AJ, Murphy JD, Rose BS. PMID: 35492227; PMCID: PMC9045578.
      View in: PubMed   Mentions: 2  
    26. Prostate weight and prostate cancer outcomes after radical prostatectomy: Results from the SEARCH cohort study. Prostate. 2022 02; 82(3):366-372. Barlow SK, Oyekunle T, Janes JL, De Hoedt AM, Aronson WJ, Kane CJ, Amling CL, Cooperberg MR, Klaassen ZW, Terris MK, Freedland SJ, Csizmadi I. PMID: 34905632.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    27. Disparities and trends in the participation of minorities, women, and the elderly in breast, colorectal, lung, and prostate cancer clinical trials. Cancer. 2022 02 15; 128(4):770-777. Javier-DesLoges J, Nelson TJ, Murphy JD, McKay RR, Pan E, Parsons JK, Kane CJ, Kader AK, Derweesh IH, Nodora J, Patel SP, Martinez ME, Rose BS. PMID: 34806168.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    28. Association between Delay to Radical Prostatectomy and Clinically Meaningful Outcomes among Patients with Intermediate and High-Risk Localized Prostate Cancer. J Urol. 2022 03; 207(3):592-600. Lee MC, Erickson TR, Stock S, Howard LE, De Hoedt AM, Amling CL, Aronson WJ, Cooperberg MR, Kane CJ, Terris MK, Klaassen Z, Freedland SJ, Wallis CJD. PMID: 34694910.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    29. Adjuvant therapy in patients with sarcomatoid renal cell carcinoma: post hoc analysis from Eastern Cooperative Oncology Group-American College of Radiology Imaging Network (ECOG-ACRIN) E2805. BJU Int. 2022 06; 129(6):718-722. Karam JA, Puligandla M, Flaherty KT, Uzzo RG, Matin SF, Pins MR, Wood CG, Kane C, Jewett MAS, Kim SE, Dutcher JP, DiPaola RS, Haas NB. PMID: 34480522; PMCID: PMC9423939.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    30. Re: Association of Black Race with Prostate Cancer-specific and Other-cause Mortality. Eur Urol. 2021 12; 80(6):758-759. Ghali F, Kane CJ. PMID: 34535345.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    31. A PSMA-targeted bispecific antibody for prostate cancer driven by a small-molecule targeting ligand. Sci Adv. 2021 08; 7(33). Lee SC, Ma JSY, Kim MS, Laborda E, Choi SH, Hampton EN, Yun H, Nunez V, Muldong MT, Wu CN, Ma W, Kulidjian AA, Kane CJ, Klyushnichenko V, Woods AK, Joseph SB, Petrassi M, Wisler J, Li J, Jamieson CAM, Schultz PG, Kim CH, Young TS. PMID: 34380625; PMCID: PMC8357232.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    32. Time Trends in Use of Radical Prostatectomy by Tumor Risk and Life Expectancy in a National Veterans Affairs Cohort. JAMA Netw Open. 2021 06 01; 4(6):e2112214. Vaculik K, Luu M, Howard LE, Aronson W, Terris M, Kane C, Amling C, Cooperberg M, Freedland SJ, Daskivich TJ. PMID: 34081138; PMCID: PMC8176332.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    33. Focus on Transitional Disease: A Critical Interval to Delay Progression of Prostate Cancer. Oncology (Williston Park). 2021 04 19; 35(4):166. Crawford ED, Kane CJ, Harris RG, Bryce AH, Petrylak DP. PMID: 33872479.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    34. Experience with 10 years of a robotic surgery program at an Academic Medical Center. Surg Endosc. 2022 03; 36(3):1950-1960. Stringfield SB, Parry LA, Eisenstein SG, Horgan SN, Kane CJ, Ramamoorthy SL. PMID: 33844089; PMCID: PMC8847263.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    35. Safety of concomitant therapy with radium-223 and abiraterone or enzalutamide in a real-world population. Prostate. 2021 05; 81(7):390-397. Zhao H, Howard LE, De Hoedt AM, Terris MK, Amling CL, Kane CJ, Cooperberg MR, Aronson WJ, Klaassen Z, Polascik TJ, Vidal AC, Freedland SJ. PMID: 33705584.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    36. Predicting Disease Recurrence, Early Progression, and Overall Survival Following Surgical Resection for High-risk Localized and Locally Advanced Renal Cell Carcinoma. Eur Urol. 2021 07; 80(1):20-31. Correa AF, Jegede OA, Haas NB, Flaherty KT, Pins MR, Adeniran A, Messing EM, Manola J, Wood CG, Kane CJ, Jewett MAS, Dutcher JP, DiPaola RS, Carducci MA, Uzzo RG. PMID: 33707112; PMCID: PMC8627688.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    37. Diabetes and Prostate Cancer Outcomes in Obese and Nonobese Men After Radical Prostatectomy. JNCI Cancer Spectr. 2021 06; 5(3). Kelkar S, Oyekunle T, Eisenberg A, Howard L, Aronson WJ, Kane CJ, Amling CL, Cooperberg MR, Klaassen Z, Terris MK, Freedland SJ, Csizmadi I. PMID: 34169227; PMCID: PMC8220304.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    38. Randomized Blinded Placebo-Controlled Trials of Renal Sympathetic Denervation for Hypertension: A Meta-Analysis. Cardiovasc Revasc Med. 2022 01; 34:112-118. Ahmad Y, Kane C, Arnold AD, Cook CM, Keene D, Shun-Shin M, Cole G, Al-Lamee R, Francis DP, Howard JP. PMID: 33551282; PMCID: PMC8813172.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    39. Implementing Continuous Quality Improvement in an Integrated Community Urology Practice: Lessons Learned. Urology. 2021 07; 153:139-146. Gaylis F, Nasseri R, Salmasi A, Anderson C, Mohedin S, Prime R, Swift S, Dato P, Cohen E, Catalona W, Topp R, Friedman L, Kane C. PMID: 33482125.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    40. Monocyte counts and prostate cancer outcomes in white and black men: results from the SEARCH database. Cancer Causes Control. 2021 Feb; 32(2):189-197. Yirga A, Oyekunle T, Howard LE, De Hoedt AM, Cooperberg MR, Kane CJ, Aronson WJ, Terris MK, Amling CL, Taioli E, Fowke JH, Klaanssen Z, Freedland SJ, Vidal AC. PMID: 33392907; PMCID: PMC7856261.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    41. Development and Validation of a Clinical Prognostic Stage Group System for Nonmetastatic Prostate Cancer Using Disease-Specific Mortality Results From the International Staging Collaboration for Cancer of the Prostate. JAMA Oncol. 2020 12 01; 6(12):1912-1920. Dess RT, Suresh K, Zelefsky MJ, Freedland SJ, Mahal BA, Cooperberg MR, Davis BJ, Horwitz EM, Terris MK, Amling CL, Aronson WJ, Kane CJ, Jackson WC, Hearn JWD, Deville C, DeWeese TL, Greco S, McNutt TR, Song DY, Sun Y, Mehra R, Kaffenberger SD, Morgan TM, Nguyen PL, Feng FY, Sharma V, Tran PT, Stish BJ, Pisansky TM, Zaorsky NG, Moraes FY, Berlin A, Finelli A, Fossati N, Gandaglia G, Briganti A, Carroll PR, Karnes RJ, Kattan MW, Schipper MJ, Spratt DE. PMID: 33090219; PMCID: PMC7582232.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    42. Do Hispanic Men Have Worse Outcomes After Radical Prostatectomy? Results From SEARCH. Urology. 2021 03; 149:181-186. Guerrios-Rivera L, Howard LE, Klaassen Z, Terris MK, Cooperberg MR, Amling CL, Kane CJ, Aronson WJ, Freedland SJ. PMID: 33189734.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    43. Association Between African American Race and Clinical Outcomes in Men Treated for Low-Risk Prostate Cancer With Active Surveillance. JAMA. 2020 11 03; 324(17):1747-1754. Deka R, Courtney PT, Parsons JK, Nelson TJ, Nalawade V, Luterstein E, Cherry DR, Simpson DR, Mundt AJ, Murphy JD, D'Amico AV, Kane CJ, Martinez ME, Rose BS. PMID: 33141207; PMCID: PMC7610194.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    44. Medical Undistancing Through Telemedicine: A Model Enabling Rapid Telemedicine Deployment in an Academic Health Center During the COVID-19 Pandemic. Telemed J E Health. 2021 06; 27(6):625-634. Meyer BC, Friedman LS, Payne K, Moore L, Cressler J, Holberg S, Partridge B, Prince B, Sylwestrzak M, Jenusaitis M, Kremer B, Kane CJ, Sitapati A, Clay B, Millen M, Longhurst C. PMID: 33030985.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCellsPHPublic Health
    45. Evolving understanding and categorization of prostate cancer: preventing progression to metastatic castration-resistant prostate cancer: RADAR IV. Can J Urol. 2020 10; 27(5):10352-10362. Crawford ED, Andriole G, Freedland SJ, Garnick M, Gomella LG, Henderson J, Higano CT, Kader AK, Kane C, Keane TE, Koo PJ, Petrylak DP, Reiter RE, Slovin SF, Yu EY. PMID: 33049187.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    46. The Impact of Comorbidity and Age on Timing of Androgen Deprivation Therapy in Men with Biochemical Recurrence after Radical Prostatectomy. Urol Pract. 2021 Mar; 8(2):238-245. Moradzadeh A, Howard LE, Freedland SJ, Amling CL, Aronson WJ, Cooperberg MR, Kane CJ, Klaassen Z, Terris MK, Daskivich TJ. PMID: 37145618.
      View in: PubMed   Mentions:
    47. Obese men undergoing radical prostatectomy: Is robotic or retropubic better to limit positive surgical margins? Results from SEARCH. Int J Urol. 2020 10; 27(10):851-857. Nik-Ahd F, Howard LE, Aronson WJ, Terris MK, Klaassen Z, Cooperberg MR, Amling CL, Kane CJ, Freedland SJ. PMID: 32681540.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    48. Testosterone therapy does not increase the risks of prostate cancer recurrence or death after definitive treatment for localized disease. Prostate Cancer Prostatic Dis. 2020 12; 23(4):689-695. Sarkar RR, Patel SH, Parsons JK, Deka R, Kumar A, Einck JP, Mundt AJ, Kader AK, Kane CJ, Riviere P, McKay R, Murphy JD, Rose BS. PMID: 32513967.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    49. Obesity, race, and long-term prostate cancer outcomes. Cancer. 2020 08 15; 126(16):3733-3741. Vidal AC, Oyekunle T, Howard LE, De Hoedt AM, Kane CJ, Terris MK, Cooperberg MR, Amling CL, Klaassen Z, Freedland SJ, Aronson WJ. PMID: 32497282.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    50. Neoadjuvant rituximab modulates the tumor immune environment in patients with high risk prostate cancer. J Transl Med. 2020 05 28; 18(1):214. Ryan ST, Zhang J, Burner DN, Liss M, Pittman E, Muldong M, Shabaik A, Woo J, Basler N, Cunha J, Shalapour S, Estrada MV, Karin M, Messer K, Howell S, Kane CJ, Jamieson CAM. PMID: 32466781; PMCID: PMC7257145.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansAnimalsCellsCTClinical Trials
    51. Leveraging the Electronic Medical Record Improves Prostate Cancer Clinical Staging in a Community Urology Practice. Urol Pract. 2021 Jan; 8(1):47-52. Gaylis F, Nasseri R, Swift S, Levy S, Prime R, Dijeh U, Prock D, Dato P, Cohen E, Kane C. PMID: 37145430.
      View in: PubMed   Mentions: 1  
    52. Race does not predict skeletal-related events and all-cause mortality in men with castration-resistant prostate cancer. Cancer. 2020 07 15; 126(14):3274-3280. Patel DN, Howard LE, De Hoedt AM, Amling CL, Aronson WJ, Cooperberg MR, Kane CJ, Klaassen ZW, Terris MK, Freedland SJ. PMID: 32374476.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    53. African-American men with low-risk prostate cancer treated with radical prostatectomy in an equal-access health care system: implications for active surveillance. Prostate Cancer Prostatic Dis. 2020 12; 23(4):581-588. Deka R, Parsons JK, Simpson DR, Riviere P, Nalawade V, Vitzthum LK, Kader AK, Kane CJ, Rock CS, Murphy JD, Rose BS. PMID: 32327702.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    54. Competing Risks of Mortality among Men with Biochemical Recurrence after Radical Prostatectomy. J Urol. 2020 Sep; 204(3):511-517. Daskivich TJ, Howard LE, Amling CL, Aronson WJ, Cooperberg MR, Kane CJ, Klaassen Z, Terris MK, Freedland SJ. PMID: 32243242.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    55. Performance of clinicopathologic models in men with high risk localized prostate cancer: impact of a 22-gene genomic classifier. Prostate Cancer Prostatic Dis. 2020 12; 23(4):646-653. Tosoian JJ, Birer SR, Jeffrey Karnes R, Zhang J, Davicioni E, Klein EE, Freedland SJ, Weinmann S, Trock BJ, Dess RT, Zhao SG, Jackson WC, Yamoah K, Dal Pra A, Mahal BA, Morgan TM, Mehra R, Kaffenberger S, Salami SS, Kane C, Pollack A, Den RB, Berlin A, Schaeffer EM, Nguyen PL, Feng FY, Spratt DE. PMID: 32231245; PMCID: PMC10184170.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    56. Effects of Percutaneous Coronary Intervention on Death and Myocardial Infarction Stratified by Stable and Unstable Coronary Artery Disease: A Meta-Analysis of Randomized Controlled Trials. Circ Cardiovasc Qual Outcomes. 2020 02; 13(2):e006363. Chacko L, P Howard J, Rajkumar C, Nowbar AN, Kane C, Mahdi D, Foley M, Shun-Shin M, Cole G, Sen S, Al-Lamee R, Francis DP, Ahmad Y. PMID: 32063040; PMCID: PMC7034389.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    57. Establishment and Analysis of Three-Dimensional (3D) Organoids Derived from Patient Prostate Cancer Bone Metastasis Specimens and their Xenografts. J Vis Exp. 2020 02 03; (156). Lee S, Burner DN, Mendoza TR, Muldong MT, Arreola C, Wu CN, Cacalano NA, Kulidjian AA, Kane CJ, Jamieson CAM. PMID: 32065165.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    58. Low Penetrance Germline Genetic Testing: Role for Risk Stratification in Prostate Cancer Screening and Examples From Clinical Practice. Rev Urol. 2020; 22(4):152-158. Gaylis F, Bree KK, Dato P, Andriole GL, Kane CJ, Kader AK. PMID: 33927572; PMCID: PMC8058920.
      View in: PubMed   Mentions:
    59. Reply by Authors. J Urol. 2020 01; 203(1):127. Dambal S, Howard LE, Allott EH, Aronson WJ, Kane CJ, Amling CL, Cooperberg MR, Terris MK, Freedland SJ. PMID: 31609668.
      View in: PubMed   Mentions:    Fields:    
    60. Local Recurrence Following Resection of Intermediate-High Risk Nonmetastatic Renal Cell Carcinoma: An Anatomical Classification and Analysis of the ASSURE (ECOG-ACRIN E2805) Adjuvant Trial. J Urol. 2020 04; 203(4):684-689. Lee Z, Jegede OA, Haas NB, Pins MR, Messing EM, Manola J, Wood CG, Kane CJ, Jewett MAS, Flaherty KT, Dutcher JP, DiPaola RS, Uzzo RG. PMID: 31596672; PMCID: PMC7337326.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    61. Racial Discrepancies in Overall Survival among Men Treated with 223Radium. J Urol. 2020 02; 203(2):331-337. Zhao H, Howard LE, De Hoedt A, Terris MK, Amling CL, Kane CJ, Cooperberg MR, Aronson WJ, Klaassen Z, Polascik TJ, Vidal AC, Freedland SJ. PMID: 31479407.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    62. Serum Lipids prior to Starting Androgen Deprivation Therapy and Risk of Castration Resistant Prostate Cancer and Metastasis: Results from the SEARCH Database. J Urol. 2020 01; 203(1):120-127. Dambal S, Howard LE, Allott EH, Aronson WJ, Kane CJ, Amling CL, Cooperberg MR, Terris MK, Freedland SJ. PMID: 31430247.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    63. Predictors of skeletal-related events and mortality in men with metastatic, castration-resistant prostate cancer: Results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. Cancer. 2019 11 15; 125(22):4003-4010. Tablazon IL, Howard LE, De Hoedt AM, Aronson WJ, Kane CJ, Amling CL, Cooperberg MR, Terris MK, Freedland SJ, Williams SB. PMID: 31390061; PMCID: PMC6819222.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    64. Association of Black Race With Prostate Cancer-Specific and Other-Cause Mortality. JAMA Oncol. 2019 07 01; 5(7):975-983. Dess RT, Hartman HE, Mahal BA, Soni PD, Jackson WC, Cooperberg MR, Amling CL, Aronson WJ, Kane CJ, Terris MK, Zumsteg ZS, Butler S, Osborne JR, Morgan TM, Mehra R, Salami SS, Kishan AU, Wang C, Schaeffer EM, Roach M, Pisansky TM, Shipley WU, Freedland SJ, Sandler HM, Halabi S, Feng FY, Dignam JJ, Nguyen PL, Schipper MJ, Spratt DE. PMID: 31120534; PMCID: PMC6547116.
      View in: PubMed   Mentions: 150     Fields:    Translation:HumansCTClinical Trials
    65. Predicting Renal Cancer Recurrence: Defining Limitations of Existing Prognostic Models With Prospective Trial-Based Validation. J Clin Oncol. 2019 08 10; 37(23):2062-2071. Correa AF, Jegede O, Haas NB, Flaherty KT, Pins MR, Messing EM, Manola J, Wood CG, Kane CJ, Jewett MAS, Dutcher JP, DiPaola RS, Carducci MA, Uzzo RG. PMID: 31216227; PMCID: PMC7085167.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    66. Association of Treatment With 5α-Reductase Inhibitors With Time to Diagnosis and Mortality in Prostate Cancer. JAMA Intern Med. 2019 06 01; 179(6):812-819. Sarkar RR, Parsons JK, Bryant AK, Ryan ST, Kader AK, McKay RR, D'Amico AV, Nguyen PL, Hulley BJ, Einck JP, Mundt AJ, Kane CJ, Murphy JD, Rose BS. PMID: 31058923; PMCID: PMC6503564.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    67. Salvage Radiotherapy for Recurrent Prostate Cancer: Can the Prognostic Grade Group System Inform Treatment Timing? Clin Genitourin Cancer. 2019 10; 17(5):e930-e938. Tay KJ, Polascik TJ, Howard LE, Salama JK, Schulman AA, Chen Z, Amling CL, Aronson WJ, Cooperberg MR, Kane CJ, Terris MK, Freedland SJ. PMID: 31257075.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    68. Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2019 05 01; 17(5):479-505. Mohler JL, Antonarakis ES, Armstrong AJ, D'Amico AV, Davis BJ, Dorff T, Eastham JA, Enke CA, Farrington TA, Higano CS, Horwitz EM, Hurwitz M, Ippolito JE, Kane CJ, Kuettel MR, Lang JM, McKenney J, Netto G, Penson DF, Plimack ER, Pow-Sang JM, Pugh TJ, Richey S, Roach M, Rosenfeld S, Schaeffer E, Shabsigh A, Small EJ, Spratt DE, Srinivas S, Tward J, Shead DA, Freedman-Cass DA. PMID: 31085757.
      View in: PubMed   Mentions: 471     Fields:    Translation:Humans
    69. Influence of African American race on the association between preoperative biopsy grade group and adverse histopathologic features of radical prostatectomy. Cancer. 2019 09 01; 125(17):3025-3032. Aminsharifi A, Schulman A, Howard LE, Tay KJ, Amling CL, Aronson WJ, Cooperberg MR, Kane CJ, Terris MK, Freedland SJ, Polascik TJ. PMID: 31042315.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    70. Poorly controlled diabetes increases the risk of metastases and castration-resistant prostate cancer in men undergoing radical prostatectomy: Results from the SEARCH database. Cancer. 2019 08 15; 125(16):2861-2867. Nik-Ahd F, Howard LE, Eisenberg AT, Aronson WJ, Terris MK, Cooperberg MR, Amling CL, Kane CJ, Freedland SJ. PMID: 31034601; PMCID: PMC6663572.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    71. Validity of the National Death Index to ascertain the date and cause of death in men having undergone prostatectomy for prostate cancer. Prostate Cancer Prostatic Dis. 2019 12; 22(4):633-635. Moghanaki D, Howard LE, De Hoedt A, Aronson WJ, Kane CJ, Amling CL, Cooperberg MR, Terris MK, Freedland SJ. PMID: 31036926; PMCID: PMC6819236.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    72. First-year weight loss with androgen-deprivation therapy increases risks of prostate cancer progression and prostate cancer-specific mortality: results from SEARCH. Cancer Causes Control. 2019 Mar; 30(3):259-269. Griffin K, Csizmadi I, Howard LE, Pomann GM, Aronson WJ, Kane CJ, Amling CL, Cooperberg MR, Terris MK, Beebe-Dimmer J, Freedland SJ. PMID: 30701374; PMCID: PMC6599459.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    73. Neoadjuvant Sunitinib Decreases Inferior Vena Caval Thrombus Size and Is Associated With Improved Oncologic Outcomes: A Multicenter Comparative Analysis. Clin Genitourin Cancer. 2019 06; 17(3):e505-e512. Field CA, Cotta BH, Jimenez J, Lane BR, Yim K, Lee HJ, Ryan ST, Hamilton ZA, Patel S, Wang S, Kane CJ, Dey S, Mckay RR, Noyes S, Millard FE, Rini BI, Campbell SC, Derweesh IH. PMID: 30808547.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    74. Practice patterns and outcomes of equivocal bone scans for patients with castration-resistant prostate cancer: Results from SEARCH. Asian J Urol. 2019 Jul; 6(3):242-248. Hanyok BT, Everist MM, Howard LE, De Hoedt AM, Aronson WJ, Cooperberg MR, Kane CJ, Amling CL, Terris MK, Freedland SJ. PMID: 31297315; PMCID: PMC6595156.
      View in: PubMed   Mentions: 2  
    75. Socioeconomic status, race, and long-term outcomes after radical prostatectomy in an equal access health system: Results from the SEARCH database. Urol Oncol. 2019 04; 37(4):289.e11-289.e17. Everist MM, Howard LE, Aronson WJ, Kane CJ, Amling CL, Cooperberg MR, Terris MK, Freedland SJ. PMID: 30598238; PMCID: PMC6440810.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    76. Subcastrate Testosterone Nadir and Clinical Outcomes in Intermediate- or High-Risk Localized Prostate Cancer. Int J Radiat Oncol Biol Phys. 2019 04 01; 103(5):1068-1076. Bryant AK, McKay RR, Kader AK, Parsons JK, Einck JP, Kane CJ, Mundt AJ, Murphy JD, Rose BS. PMID: 30543857.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    77. Obesity, risk of biochemical recurrence, and prostate-specific antigen doubling time after radical prostatectomy: results from the SEARCH database. BJU Int. 2019 07; 124(1):69-75. Freedland SJ, Branche BL, Howard LE, Hamilton RJ, Aronson WJ, Terris MK, Cooperberg MR, Amling CL, Kane CJ, SEARCH Database Study Group. PMID: 30347135; PMCID: PMC6476692.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    78. Does race predict the development of metastases in men who receive androgen-deprivation therapy for a biochemical recurrence after radical prostatectomy? Cancer. 2019 02 01; 125(3):434-441. Vidal AC, Howard LE, De Hoedt A, Kane CJ, Terris MK, Aronson WJ, Cooperberg MR, Amling CL, Lechpammer S, Flanders SC, Freedland SJ. PMID: 30427535; PMCID: PMC6340729.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    79. Association between Radical Prostatectomy and Survival in Men with Clinically Node-positive Prostate Cancer. Eur Urol Oncol. 2019 09; 2(5):584-588. Sarkar RR, Bryant AK, Parsons JK, Ryan ST, Karim Kader A, Kane CJ, McKay RR, Sandhu A, Murphy JD, Rose BS. PMID: 31411995; PMCID: PMC6697241.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    80. Statins are Associated With Increased Biochemical Recurrence After Radical Prostatectomy in Diabetic Men but no Association was Seen in Men also Taking Metformin: Results From the SEARCH Database. Clin Genitourin Cancer. 2019 Feb; 17(1):e140-e149. Aminsharifi A, Howard LE, Amling CL, Aronson WJ, Cooperberg MR, Kane CJ, Terris MK, Polascik TJ, Freedland SJ. PMID: 30366879.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    81. Impact of age, comorbidity, and PSA doubling time on long-term competing risks for mortality among men with non-metastatic castration-resistant prostate cancer. Prostate Cancer Prostatic Dis. 2019 05; 22(2):252-260. Whitney CA, Howard LE, Freedland SJ, DeHoedt AM, Amling CL, Aronson WJ, Cooperberg MR, Kane CJ, Terris MK, Daskivich TJ. PMID: 30279582.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    82. Impact of prior local therapy on overall survival in men with metastatic castration-resistant prostate cancer: Results from Shared Equal Access Regional Cancer Hospital. Int J Urol. 2018 12; 25(12):998-1004. Patel DN, Jha S, Howard LE, Amling CL, Aronson WJ, Cooperberg MR, Kane CJ, Terris MK, Chapin BF, Freedland SJ. PMID: 30253446; PMCID: PMC6279517.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    83. Nerve-targeted probes for fluorescence-guided intraoperative imaging. Theranostics. 2018; 8(15):4226-4237. Hingorani DV, Whitney MA, Friedman B, Kwon JK, Crisp JL, Xiong Q, Gross L, Kane CJ, Tsien RY, Nguyen QT. PMID: 30128049; PMCID: PMC6096382.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansAnimalsCells
    84. Three-month posttreatment prostate-specific antigen level as a biomarker of treatment response in patients with intermediate-risk or high-risk prostate cancer treated with androgen deprivation therapy and radiotherapy. Cancer. 2018 07 15; 124(14):2939-2947. Bryant AK, D'Amico AV, Nguyen PL, Einck JP, Kane CJ, McKay RR, Simpson DR, Mundt AJ, Murphy JD, Rose BS. PMID: 29727915.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    85. Definitive Radiation Therapy and Survival in Clinically Node-Positive Prostate Cancer. Int J Radiat Oncol Biol Phys. 2018 08 01; 101(5):1188-1193. Bryant AK, Kader AK, McKay RR, Einck JP, Mell LK, Mundt AJ, Kane CJ, Efstathiou JA, Murphy JD, Rose BS. PMID: 29891203.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    86. Neutrophil, lymphocyte and platelet counts, and risk of prostate cancer outcomes in white and black men: results from the SEARCH database. Cancer Causes Control. 2018 06; 29(6):581-588. Vidal AC, Howard LE, de Hoedt A, Cooperberg MR, Kane CJ, Aronson WJ, Terris MK, Amling CL, Taioli E, Fowke JH, Freedland SJ. PMID: 29663110; PMCID: PMC5940530.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    87. Obese patients with castration-resistant prostate cancer may be at a lower risk of all-cause mortality: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. BJU Int. 2018 07; 122(1):76-82. Vidal AC, Howard LE, de Hoedt A, Kane CJ, Terris MK, Aronson WJ, Cooperberg MR, Amling CL, Freedland SJ. PMID: 29521009; PMCID: PMC5997525.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    88. Positive Surgical Margins in the 10 Most Common Solid Cancers. Sci Rep. 2018 04 09; 8(1):5686. Orosco RK, Tapia VJ, Califano JA, Clary B, Cohen EEW, Kane C, Lippman SM, Messer K, Molinolo A, Murphy JD, Pang J, Sacco A, Tringale KR, Wallace A, Nguyen QT. PMID: 29632347; PMCID: PMC5890246.
      View in: PubMed   Mentions: 70     Fields:    Translation:Humans
    89. Radical prostatectomy and the effect of close surgical margins: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. BJU Int. 2018 10; 122(4):592-598. Herforth C, Stroup SP, Chen Z, Howard LE, Freedland SJ, Moreira DM, Terris MK, Aronson WJ, Cooperberg MR, Amling CL, Kane CJ. PMID: 29473992.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    90. First postoperative PSA is associated with outcomes in patients with node positive prostate cancer: Results from the SEARCH database. Urol Oncol. 2018 May; 36(5):239.e17-239.e25. McDonald ML, Howard LE, Aronson WJ, Terris MK, Cooperberg MR, Amling CL, Freedland SJ, Kane CJ. PMID: 29429895.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    91. Analysis of T1 Bladder Cancer on Biopsy and Transurethral Resection Specimens: Comparison and Ranking of T1 Quantification Approaches to Predict Progression to Muscularis Propria Invasion. Am J Surg Pathol. 2018 Jan; 42(1):e1-e10. Leivo MZ, Sahoo D, Hamilton Z, Mirsadraei L, Shabaik A, Parsons JK, Kader AK, Derweesh I, Kane C, Hansel DE. PMID: 29076872.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    92. Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017. J Clin Oncol. 2018 02 01; 36(4):414-424. Giri VN, Knudsen KE, Kelly WK, Abida W, Andriole GL, Bangma CH, Bekelman JE, Benson MC, Blanco A, Burnett A, Catalona WJ, Cooney KA, Cooperberg M, Crawford DE, Den RB, Dicker AP, Eggener S, Fleshner N, Freedman ML, Hamdy FC, Hoffman-Censits J, Hurwitz MD, Hyatt C, Isaacs WB, Kane CJ, Kantoff P, Karnes RJ, Karsh LI, Klein EA, Lin DW, Loughlin KR, Lu-Yao G, Malkowicz SB, Mann MJ, Mark JR, McCue PA, Miner MM, Morgan T, Moul JW, Myers RE, Nielsen SM, Obeid E, Pavlovich CP, Peiper SC, Penson DF, Petrylak D, Pettaway CA, Pilarski R, Pinto PA, Poage W, Raj GV, Rebbeck TR, Robson ME, Rosenberg MT, Sandler H, Sartor O, Schaeffer E, Schwartz GF, Shahin MS, Shore ND, Shuch B, Soule HR, Tomlins SA, Trabulsi EJ, Uzzo R, Vander Griend DJ, Walsh PC, Weil CJ, Wender R, Gomella LG. PMID: 29236593; PMCID: PMC6075860.
      View in: PubMed   Mentions: 73     Fields:    Translation:Humans
    93. Development and Validation of a Novel Integrated Clinical-Genomic Risk Group Classification for Localized Prostate Cancer. J Clin Oncol. 2018 02 20; 36(6):581-590. Spratt DE, Zhang J, Santiago-Jiménez M, Dess RT, Davis JW, Den RB, Dicker AP, Kane CJ, Pollack A, Stoyanova R, Abdollah F, Ross AE, Cole A, Uchio E, Randall JM, Nguyen H, Zhao SG, Mehra R, Glass AG, Lam LLC, Chelliserry J, du Plessis M, Choeurng V, Aranes M, Kolisnik T, Margrave J, Alter J, Jordan J, Buerki C, Yousefi K, Haddad Z, Davicioni E, Trabulsi EJ, Loeb S, Tewari A, Carroll PR, Weinmann S, Schaeffer EM, Klein EA, Karnes RJ, Feng FY, Nguyen PL. PMID: 29185869; PMCID: PMC6530900.
      View in: PubMed   Mentions: 58     Fields:    Translation:Humans
    94. Modified risk stratification grouping using standard clinical and biopsy information for patients undergoing radical prostatectomy: Results from SEARCH. Prostate. 2017 Dec; 77(16):1592-1600. Zumsteg ZS, Chen Z, Howard LE, Amling CL, Aronson WJ, Cooperberg MR, Kane CJ, Terris MK, Spratt DE, Sandler HM, Freedland SJ. PMID: 28994485; PMCID: PMC5685668.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    95. Does Early Prostate Specific Antigen Doubling Time after Radical Prostatectomy, Calculated Prior to Prostate Specific Antigen Recurrence, Correlate with Prostate Cancer Outcomes? A Report from the SEARCH Database Group. J Urol. 2018 03; 199(3):713-718. Teeter AE, Griffin K, Howard LE, Aronson WJ, Terris MK, Kane CJ, Amling CL, Cooperberg MR, Freedland SJ. PMID: 28870860.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    96. Timing of Prostate-specific Antigen Nadir After Radical Prostatectomy and Risk of Biochemical Recurrence. Urology. 2017 Oct; 108:129-134. Skove SL, Howard LE, Aronson WJ, Terris MK, Kane CJ, Amling CL, Cooperberg MR, Moreira DM, Freedland SJ. PMID: 28735016; PMCID: PMC6150912.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    97. Retroperitoneal Lymphadenectomy for High Risk, Nonmetastatic Renal Cell Carcinoma: An Analysis of the ASSURE (ECOG-ACRIN 2805) Adjuvant Trial. J Urol. 2018 01; 199(1):53-59. Ristau BT, Manola J, Haas NB, Heng DYC, Messing EM, Wood CG, Kane CJ, DiPaola RS, Uzzo RG. PMID: 28728992; PMCID: PMC5800986.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    98. Predictors of operative time during radical retropubic prostatectomy and robot-assisted laparoscopic prostatectomy. Int J Urol. 2017 08; 24(8):618-623. Simon RM, Howard LE, Moreira DM, Terris MK, Kane CJ, Aronson WJ, Amling CL, Cooperberg MR, Freedland SJ. PMID: 28697533.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    99. Biopsy Detected Gleason Pattern 5 is Associated with Recurrence, Metastasis and Mortality in a Cohort of Men with High Risk Prostate Cancer. J Urol. 2017 12; 198(6):1309-1315. Stroup SP, Moreira DM, Chen Z, Howard L, Berger JH, Terris MK, Aronson WJ, Cooperberg MR, Amling CL, Kane CJ, Freedland SJ. PMID: 28709888; PMCID: PMC6946381.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    100. Validation of the 2015 prostate cancer grade groups for predicting long-term oncologic outcomes in a shared equal-access health system. Cancer. 2017 Nov 01; 123(21):4122-4129. Schulman AA, Howard LE, Tay KJ, Tsivian E, Sze C, Amling CL, Aronson WJ, Cooperberg MR, Kane CJ, Terris MK, Freedland SJ, Polascik TJ. PMID: 28662291; PMCID: PMC6986737.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    101. Race and risk of metastases and survival after radical prostatectomy: Results from the SEARCH database. Cancer. 2017 Nov 01; 123(21):4199-4206. Freedland SJ, Vidal AC, Howard LE, Terris MK, Cooperberg MR, Amling CL, Kane CJ, Aronson WJ, Shared Equal Access Regional Cancer Hospital (SEARCH) Database Study Group. PMID: 28654204; PMCID: PMC5650540.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    102. Characterization of a "low-risk" cohort of grade group 2 prostate cancer patients: Results from the Shared Equal Access Regional Cancer Hospital database. Int J Urol. 2017 08; 24(8):611-617. McGinley KF, Sun X, Howard LE, Aronson WJ, Terris MK, Kane CJ, Amling CL, Cooperberg MR, Freedland SJ. PMID: 28589550; PMCID: PMC6986736.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    103. Ability of a Genomic Classifier to Predict Metastasis and Prostate Cancer-specific Mortality after Radiation or Surgery based on Needle Biopsy Specimens. Eur Urol. 2017 11; 72(5):845-852. Nguyen PL, Haddad Z, Ross AE, Martin NE, Deheshi S, Lam LLC, Chelliserry J, Tosoian JJ, Lotan TL, Spratt DE, Stoyanova RS, Punnen S, Ong K, Buerki C, Aranes M, Kolisnik T, Margrave J, Yousefi K, Choeurng V, Davicioni E, Trock BJ, Kane CJ, Pollack A, Davis JW, Feng FY, Klein EA. PMID: 28528811.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCells
    104. Thresholds for PSA doubling time in men with non-metastatic castration-resistant prostate cancer. BJU Int. 2017 11; 120(5B):E80-E86. Howard LE, Moreira DM, De Hoedt A, Aronson WJ, Kane CJ, Amling CL, Cooperberg MR, Terris MK, Freedland SJ. PMID: 28371163; PMCID: PMC5617753.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    105. Variability in Outcomes for Patients with Intermediate-risk Prostate Cancer (Gleason Score 7, International Society of Urological Pathology Gleason Group 2-3) and Implications for Risk Stratification: A Systematic Review. Eur Urol Focus. 2017 10; 3(4-5):487-497. Kane CJ, Eggener SE, Shindel AW, Andriole GL. PMID: 28753804.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    106. Fluorescence-Based Molecular Imaging of Porcine Urinary Bladder Sentinel Lymph Nodes. J Nucl Med. 2017 04; 58(4):547-553. Lee HJ, Barback CV, Hoh CK, Qin Z, Kader K, Hall DJ, Vera DR, Kane CJ. PMID: 28153955; PMCID: PMC6945107.
      View in: PubMed   Mentions: 8     Fields:    Translation:Animals
    107. Factors predicting skeletal-related events in patients with bone metastatic castration-resistant prostate cancer. Cancer. 2017 05 01; 123(9):1528-1535. Klaassen Z, Howard LE, de Hoedt A, Amling CL, Aronson WJ, Cooperberg MR, Kane CJ, Terris MK, Freedland SJ. PMID: 28026865; PMCID: PMC5562436.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    108. Obesity and prostate cancer-specific mortality after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. Prostate Cancer Prostatic Dis. 2017 03; 20(1):72-78. Vidal AC, Howard LE, Sun SX, Cooperberg MR, Kane CJ, Aronson WJ, Terris MK, Amling CL, Freedland SJ. PMID: 27698439; PMCID: PMC5303130.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    109. Long-term oncological outcomes of apical positive surgical margins at radical prostatectomy in the Shared Equal Access Regional Cancer Hospital cohort. Prostate Cancer Prostatic Dis. 2016 12; 19(4):423-428. Wadhwa H, Terris MK, Aronson WJ, Kane CJ, Amling CL, Cooperberg MR, Freedland SJ, Abern MR. PMID: 27698440.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    110. Number of Unfavorable Intermediate-Risk Factors Predicts Pathologic Upstaging and Prostate Cancer-Specific Mortality Following Radical Prostatectomy: Results From the SEARCH Database. Prostate. 2017 02; 77(2):154-163. Zumsteg ZS, Chen Z, Howard LE, Amling CL, Aronson WJ, Cooperberg MR, Kane CJ, Terris MK, Spratt DE, Sandler HM, Freedland SJ. PMID: 27683213.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    111. Systemic GM-CSF Recruits Effector T Cells into the Tumor Microenvironment in Localized Prostate Cancer. Cancer Immunol Res. 2016 11; 4(11):948-958. Wei XX, Chan S, Kwek S, Lewis J, Dao V, Zhang L, Cooperberg MR, Ryan CJ, Lin AM, Friedlander TW, Rini B, Kane C, Simko JP, Carroll PR, Small EJ, Fong L. PMID: 27688020; PMCID: PMC5115633.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    112. Specific bone region localization of osteolytic versus osteoblastic lesions in a patient-derived xenograft model of bone metastatic prostate cancer. Asian J Urol. 2016 Oct; 3(4):229-239. Hirata T, Park SC, Muldong MT, Wu CN, Yamaguchi T, Strasner A, Raheem O, Kumon H, Sah RL, Cacalano NA, Jamieson CHM, Kane CJ, Masuda K, Kulidjian AA, Jamieson CAM. PMID: 29264191; PMCID: PMC5730873.
      View in: PubMed   Mentions: 4  
    113. Predicting Time From Metastasis to Overall Survival in Castration-Resistant Prostate Cancer: Results From SEARCH. Clin Genitourin Cancer. 2017 02; 15(1):60-66.e2. Moreira DM, Howard LE, Sourbeer KN, Amarasekara HS, Chow LC, Cockrell DC, Pratson CL, Hanyok BT, Aronson WJ, Kane CJ, Terris MK, Amling CL, Cooperberg MR, Freedland SJ. PMID: 27692812; PMCID: PMC5536956.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    114. In Men with Castration-Resistant Prostate Cancer, Visceral Metastases Predict Shorter Overall Survival: What Predicts Visceral Metastases? Results from the SEARCH Database. Eur Urol Focus. 2017 10; 3(4-5):480-486. Whitney CA, Howard LE, Posadas EM, Amling CL, Aronson WJ, Cooperberg MR, Kane CJ, Terris MK, Freedland SJ. PMID: 28753787.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    115. Restriction spectrum imaging: An evolving imaging biomarker in prostate MRI. J Magn Reson Imaging. 2017 02; 45(2):323-336. Brunsing RL, Schenker-Ahmed NM, White NS, Parsons JK, Kane C, Kuperman J, Bartsch H, Kader AK, Rakow-Penner R, Seibert TM, Margolis D, Raman SS, McDonald CR, Farid N, Kesari S, Hansel D, Shabaik A, Dale AM, Karow DS. PMID: 27527500; PMCID: PMC5222783.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    116. Race does not predict the development of metastases in men with nonmetastatic castration-resistant prostate cancer. Cancer. 2016 Dec 15; 122(24):3848-3855. Whitney CA, Howard LE, Amling CL, Aronson WJ, Cooperberg MR, Kane CJ, Terris MK, Freedland SJ. PMID: 27505036.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    117. Do skeletal-related events predict overall survival in men with metastatic castration-resistant prostate cancer? Prostate Cancer Prostatic Dis. 2016 12; 19(4):380-384. Howard LE, De Hoedt AM, Aronson WJ, Kane CJ, Amling CL, Cooperberg MR, Terris MK, Divers CH, Valderrama A, Freedland SJ. PMID: 27377207; PMCID: PMC5542570.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    118. Evaluation of a genomic classifier in radical prostatectomy patients with lymph node metastasis. Res Rep Urol. 2016; 8:77-84. Lee HJ, Yousefi K, Haddad Z, Abdollah F, Lam LL, Shin H, Alshalalfa M, Godebu E, Wang S, Shabaik A, Davicioni E, Kane CJ. PMID: 27419104; PMCID: PMC4935177.
      View in: PubMed   Mentions: 7  
    119. Pathological and Biochemical Outcomes among African-American and Caucasian Men with Low Risk Prostate Cancer in the SEARCH Database: Implications for Active Surveillance Candidacy. J Urol. 2016 11; 196(5):1408-1414. Leapman MS, Freedland SJ, Aronson WJ, Kane CJ, Terris MK, Walker K, Amling CL, Carroll PR, Cooperberg MR. PMID: 27352635; PMCID: PMC5542578.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    120. Weight Loss Following Radical Cystectomy for Bladder Cancer: Characterization and Effect on Survival. Clin Genitourin Cancer. 2017 02; 15(1):86-92. McDonald ML, Liss MA, Nseyo UU, Gal DB, Kane CJ, Kader AK. PMID: 27460433.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    121. Predictors of Time to Metastasis in Castration-resistant Prostate Cancer. Urology. 2016 Oct; 96:171-176. Moreira DM, Howard LE, Sourbeer KN, Amarasekara HS, Chow LC, Cockrell DC, Hanyok BT, Aronson WJ, Kane CJ, Terris MK, Amling CL, Cooperberg MR, Liede A, Freedland SJ. PMID: 27318265; PMCID: PMC5536963.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    122. Voxel Level Radiologic-Pathologic Validation of Restriction Spectrum Imaging Cellularity Index with Gleason Grade in Prostate Cancer. Clin Cancer Res. 2016 06 01; 22(11):2668-74. Yamin G, Schenker-Ahmed NM, Shabaik A, Adams D, Bartsch H, Kuperman J, White NS, Rakow-Penner RA, McCammack K, Parsons JK, Kane CJ, Dale AM, Karow DS. PMID: 27250935; PMCID: PMC4896066.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    123. Change in platelet count as a prognostic indicator for response to primary tyrosine kinase inhibitor therapy in metastatic renal cell carcinoma. BJU Int. 2016 Dec; 118(6):927-934. Hamilton Z, Lee HJ, Jimenez J, Lane BR, Wang S, Beksac AT, Gillis K, Alagh A, Tobert C, Randall JM, Kane CJ, Millard F, Campbell SC, Derweesh IH. PMID: 27008916.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    124. Restriction spectrum imaging improves MRI-based prostate cancer detection. Abdom Radiol (NY). 2016 05; 41(5):946-53. McCammack KC, Schenker-Ahmed NM, White NS, Best SR, Marks RM, Heimbigner J, Kane CJ, Parsons JK, Kuperman JM, Bartsch H, Desikan RS, Rakow-Penner RA, Liss MA, Margolis DJ, Raman SS, Shabaik A, Dale AM, Karow DS. PMID: 26910114; PMCID: PMC5386962.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    125. Does timing of targeted therapy for metastatic renal cell carcinoma impact treatment toxicity and surgical complications? A comparison of primary and adjuvant approaches. Can J Urol. 2016 Apr; 23(2):8227-33. Patel N, Woo J, Liss MA, Palazzi KL, Randall JM, Mehrazin R, Jabaj R, Mirheydar HS, Gillis K, Lee HJ, Patterson AL, Kane CJ, Millard F, Derweesh IH. PMID: 27085828.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    126. Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial. Lancet. 2016 May 14; 387(10032):2008-16. Haas NB, Manola J, Uzzo RG, Flaherty KT, Wood CG, Kane C, Jewett M, Dutcher JP, Atkins MB, Pins M, Wilding G, Cella D, Wagner L, Matin S, Kuzel TM, Sexton WJ, Wong YN, Choueiri TK, Pili R, Puzanov I, Kohli M, Stadler W, Carducci M, Coomes R, DiPaola RS. PMID: 26969090; PMCID: PMC4878938.
      View in: PubMed   Mentions: 227     Fields:    Translation:HumansCTClinical Trials
    127. Active Surveillance of Prostate Cancer in a Community Practice: How to Measure, Manage, and Improve? Urology. 2016 07; 93:60-7. Gaylis F, Cohen E, Calabrese R, Prime H, Dato P, Kane CJ. PMID: 26876460.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    128. Validation of a bone scan positivity risk table in non-metastatic castration-resistant prostate cancer. BJU Int. 2016 Oct; 118(4):570-7. Freedland SJ, Howard LE, Hanyok BT, Kadiyala VK, Kuang JY, Whitney CA, Wilks FR, Kane CJ, Terris MK, Amling CL, Cooperberg MR, Aronson WJ, Moreira DM. PMID: 26762961; PMCID: PMC6986739.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    129. Racial Differences in the Association Between Preoperative Serum Cholesterol and Prostate Cancer Recurrence: Results from the SEARCH Database. Cancer Epidemiol Biomarkers Prev. 2016 Mar; 25(3):547-54. Allott EH, Howard LE, Aronson WJ, Terris MK, Kane CJ, Amling CL, Cooperberg MR, Freedland SJ. PMID: 26809276; PMCID: PMC4779730.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    130. In vivo prostate cancer detection and grading using restriction spectrum imaging-MRI. Prostate Cancer Prostatic Dis. 2016 06; 19(2):168-73. McCammack KC, Kane CJ, Parsons JK, White NS, Schenker-Ahmed NM, Kuperman JM, Bartsch H, Desikan RS, Rakow-Penner RA, Adams D, Liss MA, Mattrey RF, Bradley WG, Margolis DJ, Raman SS, Shabaik A, Dale AM, Karow DS. PMID: 26754261; PMCID: PMC5340721.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    131. Prostate Cancer, Version 1.2016. J Natl Compr Canc Netw. 2016 01; 14(1):19-30. Mohler JL, Armstrong AJ, Bahnson RR, D'Amico AV, Davis BJ, Eastham JA, Enke CA, Farrington TA, Higano CS, Horwitz EM, Hurwitz M, Kane CJ, Kawachi MH, Kuettel M, Lee RJ, Meeks JJ, Penson DF, Plimack ER, Pow-Sang JM, Raben D, Richey S, Roach M, Rosenfeld S, Schaeffer E, Skolarus TA, Small EJ, Sonpavde G, Srinivas S, Strope SA, Tward J, Shead DA, Freedman-Cass DA. PMID: 26733552.
      View in: PubMed   Mentions: 249     Fields:    Translation:Humans
    132. Utilization and impact of surgical technique on the performance of pelvic lymph node dissection at radical prostatectomy: Results from the Shared Equal Access Regional Cancer Hospital database. Int J Urol. 2016 Mar; 23(3):241-6. McGinley KF, Sun X, Howard LE, Aronson WJ, Terris MK, Kane CJ, Amling CL, Cooperberg MR, Freedland SJ. PMID: 26667212.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    133. Is computed tomography a necessary part of a metastatic evaluation for castration-resistant prostate cancer? Results from the Shared Equal Access Regional Cancer Hospital Database. Cancer. 2016 Jan 15; 122(2):222-9. Hanyok BT, Howard LE, Amling CL, Aronson WJ, Cooperberg MR, Kane CJ, Terris MK, Posadas EM, Freedland SJ. PMID: 26484853.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    134. Do all men with pathological Gleason score 8-10 prostate cancer have poor outcomes? Results from the SEARCH database. BJU Int. 2016 08; 118(2):250-7. Fischer S, Lin D, Simon RM, Howard LE, Aronson WJ, Terris MK, Kane CJ, Amling CL, Cooperberg MR, Freedland SJ, Vidal AC. PMID: 26351095.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    135. Does larger tumor volume explain the higher prostate specific antigen levels in black men with prostate cancer--Results from the SEARCH database. Cancer Epidemiol. 2015 Dec; 39(6):1066-70. Klaassen Z, Howard L, Terris MK, Aronson WJ, Cooperberg MR, Amling CL, Kane CJ, Freedland SJ. PMID: 26452418; PMCID: PMC4679602.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    136. Nerve-sparing Technique During Radical Prostatectomy and its Effect on Urinary Continence. Eur Urol. 2016 Apr; 69(4):590-591. Hamilton ZA, Kane CJ. PMID: 26320380.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    137. Prostate diffusion imaging with distortion correction. Magn Reson Imaging. 2015 Nov; 33(9):1178-1181. Rakow-Penner RA, White NS, Margolis DJA, Parsons JK, Schenker-Ahmed N, Kuperman JM, Bartsch H, Choi HW, Bradley WG, Shabaik A, Huang J, Liss MA, Marks L, Kane CJ, Reiter RE, Raman SS, Karow DS, Dale AM. PMID: 26220859; PMCID: PMC4594204.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    138. Virtual reality suturing task as an objective test for robotic experience assessment. BMC Urol. 2015 Jul 03; 15:63. Liss MA, Kane CJ, Chen T, Baumgartner J, Derweesh IH. PMID: 26137869; PMCID: PMC4490698.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    139. A Family History of Lethal Prostate Cancer and Risk of Aggressive Prostate Cancer in Patients Undergoing Radical Prostatectomy. Sci Rep. 2015 Jun 26; 5:10544. Raheem OA, Cohen SA, Parsons JK, Palazzi KL, Kane CJ. PMID: 26112134; PMCID: PMC4481640.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    140. Positive surgical margins in radical prostatectomy patients do not predict long-term oncological outcomes: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) cohort. BJU Int. 2016 Feb; 117(2):244-8. Mithal P, Howard LE, Aronson WJ, Terris MK, Cooperberg MR, Kane CJ, Amling C, Freedland SJ. PMID: 26010160; PMCID: PMC4658317.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    141. Adverse pathology and undetectable ultrasensitive prostate-specific antigen after radical prostatectomy: is adjuvant radiation warranted? BJU Int. 2016 06; 117(6):897-903. Simon RM, Howard LE, Freedland SJ, Aronson WJ, Terris MK, Kane CJ, Amling CL, Cooperberg MR, Vidal AC. PMID: 26010251.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    142. Predicting bone scan positivity in non-metastatic castration-resistant prostate cancer. Prostate Cancer Prostatic Dis. 2015 Dec; 18(4):333-7. Moreira DM, Howard LE, Sourbeer KN, Amarasekara HS, Chow LC, Cockrell DC, Hanyok BT, Pratson CL, Aronson WJ, Kane CJ, Terris MK, Amling CL, Cooperberg MR, Liede A, Freedland SJ. PMID: 26171882; PMCID: PMC4640947.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    143. Agent Orange and long-term outcomes after radical prostatectomy. Urol Oncol. 2015 Jul; 33(7):329.e1-6. Ovadia AE, Terris MK, Aronson WJ, Kane CJ, Amling CL, Cooperberg MR, Freedland SJ, Abern MR. PMID: 25998746.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    144. Effects of Adjuvant Sorafenib and Sunitinib on Cardiac Function in Renal Cell Carcinoma Patients without Overt Metastases: Results from ASSURE, ECOG 2805. Clin Cancer Res. 2015 Sep 15; 21(18):4048-54. Haas NB, Manola J, Ky B, Flaherty KT, Uzzo RG, Kane CJ, Jewett M, Wood L, Wood CG, Atkins MB, Dutcher JJ, Wilding G, DiPaola RS. PMID: 25967143; PMCID: PMC4573791.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCTClinical Trials
    145. Sigmoid perforation due to toothpick ingestion leading to hydronephrosis and urosepsis. Am Surg. 2015 May; 81(5):E232-3. Zelones J, Kiyama L, Sandler BJ, Kane CJ. PMID: 25975321.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    146. Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy. Nature. 2015 May 07; 521(7550):94-8. Shalapour S, Font-Burgada J, Di Caro G, Zhong Z, Sanchez-Lopez E, Dhar D, Willimsky G, Ammirante M, Strasner A, Hansel DE, Jamieson C, Kane CJ, Klatte T, Birner P, Kenner L, Karin M. PMID: 25924065; PMCID: PMC4501632.
      View in: PubMed   Mentions: 270     Fields:    Translation:HumansAnimalsCells
    147. Smoking is a predictor of adverse pathological features at radical prostatectomy: Results from the Shared Equal Access Regional Cancer Hospital database. Int J Urol. 2015 Jul; 22(7):658-62. Zapata DF, Howard LE, Aronson WJ, Kane CJ, Terris MK, Amling CL, Cooperberg MR, Freedland SJ. PMID: 25872110.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    148. Prostate-specific antigen level, stage or Gleason score: which is best for predicting outcomes after radical prostatectomy, and does it vary by the outcome being measured? Results from Shared Equal Access Regional Cancer Hospital database. Int J Urol. 2015 Apr; 22(4):362-6. Mithal P, Howard LE, Aronson WJ, Kane CJ, Cooperberg MR, Terris MK, Amling CL, Freedland SJ. PMID: 25728968.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    149. MRI-Derived Restriction Spectrum Imaging Cellularity Index is Associated with High Grade Prostate Cancer on Radical Prostatectomy Specimens. Front Oncol. 2015; 5:30. Liss MA, White NS, Parsons JK, Schenker-Ahmed NM, Rakow-Penner R, Kuperman JM, Bartsch H, Choi HW, Mattrey RF, Bradley WG, Shabaik A, Huang J, Margolis DJ, Raman SS, Marks LS, Kane CJ, Reiter RE, Dale AM, Karow DS. PMID: 25741473; PMCID: PMC4330697.
      View in: PubMed   Mentions: 12  
    150. Novel technique for characterizing prostate cancer utilizing MRI restriction spectrum imaging: proof of principle and initial clinical experience with extraprostatic extension. Prostate Cancer Prostatic Dis. 2015 Mar; 18(1):81-5. Rakow-Penner RA, White NS, Parsons JK, Choi HW, Liss MA, Kuperman JM, Schenker-Ahmed N, Bartsch H, Mattrey RF, Bradley WG, Shabaik A, Huang J, Margolis DJ, Raman SS, Marks L, Kane CJ, Reiter RE, Karow DS, Dale AM. PMID: 25559097.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    151. Action potential morphology of human induced pluripotent stem cell-derived cardiomyocytes does not predict cardiac chamber specificity and is dependent on cell density. Biophys J. 2015 Jan 06; 108(1):1-4. Du DT, Hellen N, Kane C, Terracciano CM. PMID: 25564842; PMCID: PMC4286594.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansCells
    152. Functional crosstalk between cardiac fibroblasts and adult cardiomyocytes by soluble mediators. Cardiovasc Res. 2015 Mar 01; 105(3):260-70. Cartledge JE, Kane C, Dias P, Tesfom M, Clarke L, Mckee B, Al Ayoubi S, Chester A, Yacoub MH, Camelliti P, Terracciano CM. PMID: 25560320.
      View in: PubMed   Mentions: 72     Fields:    Translation:AnimalsCells
    153. Is clinical stage T2c prostate cancer an intermediate- or high-risk disease? Cancer. 2015 May 01; 121(9):1414-21. Klaassen Z, Singh AA, Howard LE, Feng Z, Trock B, Terris MK, Aronson WJ, Cooperberg MR, Amling CL, Kane CJ, Partin A, Han M, Freedland SJ. PMID: 25492369; PMCID: PMC4409453.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    154. Practice patterns and predictors of followup imaging after a negative bone scan in men with castration resistant prostate cancer: results from the SEARCH database. J Urol. 2015 Apr; 193(4):1232-8. Sourbeer KN, Howard LE, Moreira DM, Amarasekara HS, Chow LD, Cockrell DC, Hanyok BT, Pratson CL, Kane CJ, Terris MK, Aronson WJ, Cooperberg MR, Amling CL, Hernandez RK, Freedland SJ. PMID: 25463986.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    155. What is the incidence of kidney stones after chemotherapy in patients with lymphoproliferative or myeloproliferative disorders? Int Braz J Urol. 2014 Nov-Dec; 40(6):772-80. Mirheydar HS, Banapour P, Massoudi R, Palazzi KL, Jabaji R, Reid EG, Millard FE, Kane CJ, Sur RL. PMID: 25615245.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    156. Serum lipid profile and risk of prostate cancer recurrence: Results from the SEARCH database. Cancer Epidemiol Biomarkers Prev. 2014 Nov; 23(11):2349-56. Allott EH, Howard LE, Cooperberg MR, Kane CJ, Aronson WJ, Terris MK, Amling CL, Freedland SJ. PMID: 25304929; PMCID: PMC4221498.
      View in: PubMed   Mentions: 69     Fields:    Translation:Humans
    157. How to minimize lymphoceles and treat clinically symptomatic lymphoceles after radical prostatectomy. Curr Urol Rep. 2014 Oct; 15(10):445. Lee HJ, Kane CJ. PMID: 25129450.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    158. Diffusion-weighted imaging in cancer: physical foundations and applications of restriction spectrum imaging. Cancer Res. 2014 Sep 01; 74(17):4638-52. White NS, McDonald C, McDonald CR, Farid N, Kuperman J, Karow D, Schenker-Ahmed NM, Bartsch H, Rakow-Penner R, Holland D, Shabaik A, Bjørnerud A, Hope T, Hattangadi-Gluth J, Liss M, Parsons JK, Chen CC, Raman S, Margolis D, Reiter RE, Marks L, Kesari S, Mundt AJ, Kane CJ, Kaine CJ, Carter BS, Bradley WG, Dale AM. PMID: 25183788; PMCID: PMC4155409.
      View in: PubMed   Mentions: 85     Fields:    Translation:Humans
    159. Robotic-assisted fluorescence sentinel lymph node mapping using multimodal image guidance in an animal model. Urology. 2014 Oct; 84(4):982.e9-14. Liss MA, Stroup SP, Qin Z, Hoh CK, Hall DJ, Vera DR, Kane CJ. PMID: 25139676; PMCID: PMC4366424.
      View in: PubMed   Mentions: 7     Fields:    Translation:Animals
    160. Impact of family history on prostate cancer mortality in white men undergoing prostate specific antigen based screening. J Urol. 2015 Jan; 193(1):75-9. Liss MA, Chen H, Hemal S, Krane S, Kane CJ, Xu J, Kader AK. PMID: 25066872.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    161. Impact of renal surgery for cortical neoplasms on lipid metabolism. BJU Int. 2014 Dec; 114(6):837-43. Bagrodia A, Kopp RP, Mehrazin R, Lee HJ, Liss MA, Jabaji R, Kane CJ, Wake RW, Patterson AL, Wan JY, Derweesh IH. PMID: 24656182.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    162. Preclinical evaluation of robotic-assisted sentinel lymph node fluorescence imaging. J Nucl Med. 2014 Sep; 55(9):1552-6. Liss MA, Farshchi-Heydari S, Qin Z, Hickey SA, Hall DJ, Kane CJ, Vera DR. PMID: 25024425; PMCID: PMC4350927.
      View in: PubMed   Mentions: 6     Fields:    Translation:Animals
    163. Incorporating robot-assisted prostatectomy at a Veterans Affairs hospital: outcomes. J Endourol. 2014 Sep; 28(9):1097-102. Godebu E, Woldrich JM, Cohen SA, Kane CJ, Owens EL, Sakamoto K. PMID: 24819015.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    164. Minimally invasive cystectomy is associated with improved perioperative patient safety outcomes compared with open cystectomy in a national cohort. Urology. 2014 Aug; 84(2):314-9. Cohen SA, Mirheydar HS, Parsons JK, Palazzi KL, Liss MA, Chang DC, Kane CJ, Kader AK. PMID: 24958477.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    165. Reply: To PMID 24958477. Urology. 2014 Aug; 84(2):319-20. Cohen SA, Mirheydar HS, Parsons JK, Palazzi KL, Liss MA, Chang DC, Kane CJ, Kader AK. PMID: 24958489.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    166. Editorial comment. Urology. 2014 Jun; 83(6):1367-8. Kane CJ. PMID: 24862396.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    167. Postoperative statin use and risk of biochemical recurrence following radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. BJU Int. 2014 Nov; 114(5):661-6. Allott EH, Howard LE, Cooperberg MR, Kane CJ, Aronson WJ, Terris MK, Amling CL, Freedland SJ. PMID: 24588774; PMCID: PMC4153797.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    168. Prostate cancer, version 2.2014. J Natl Compr Canc Netw. 2014 May; 12(5):686-718. Mohler JL, Kantoff PW, Armstrong AJ, Bahnson RR, Cohen M, D'Amico AV, Eastham JA, Enke CA, Farrington TA, Higano CS, Horwitz EM, Kane CJ, Kawachi MH, Kuettel M, Kuzel TM, Lee RJ, Malcolm AW, Miller D, Plimack ER, Pow-Sang JM, Raben D, Richey S, Roach M, Rohren E, Rosenfeld S, Schaeffer E, Small EJ, Sonpavde G, Srinivas S, Stein C, Strope SA, Tward J, Shead DA, Ho M, National Comprehensive Cancer Network. PMID: 24812137.
      View in: PubMed   Mentions: 129     Fields:    Translation:Humans
    169. The impact of pathologic staging on the long-term oncologic outcomes of patients with clinically high-risk prostate cancer. Cancer. 2014 Jun 01; 120(11):1656-62. Abern MR, Terris MK, Aronson WJ, Kane CJ, Amling CL, Cooperberg MR, Freedland SJ. PMID: 24647966.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    170. Tumor infiltrating B-cells are increased in prostate cancer tissue. J Transl Med. 2014 Jan 30; 12:30. Woo JR, Liss MA, Muldong MT, Palazzi K, Strasner A, Ammirante M, Varki N, Shabaik A, Howell S, Kane CJ, Karin M, Jamieson CA. PMID: 24475900; PMCID: PMC3914187.
      View in: PubMed   Mentions: 90     Fields:    Translation:HumansAnimalsCells
    171. Predicting bone scan positivity after biochemical recurrence following radical prostatectomy in both hormone-naive men and patients receiving androgen-deprivation therapy: results from the SEARCH database. Prostate Cancer Prostatic Dis. 2014 Mar; 17(1):91-6. Moreira DM, Cooperberg MR, Howard LE, Aronson WJ, Kane CJ, Terris MK, Amling CL, Kuchibhatla M, Freedland SJ. PMID: 24418913; PMCID: PMC4564861.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    172. Robotic-assisted simple prostatectomy: a systematic review and report of a single institution case series. Prostate Cancer Prostatic Dis. 2014 Mar; 17(1):1-5. Banapour P, Patel N, Kane CJ, Cohen SA, Parsons JK. PMID: 24323329.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    173. Cigarette smoking is associated with an increased risk of biochemical disease recurrence, metastasis, castration-resistant prostate cancer, and mortality after radical prostatectomy: results from the SEARCH database. Cancer. 2014 Jan 15; 120(2):197-204. Moreira DM, Aronson WJ, Terris MK, Kane CJ, Amling CL, Cooperberg MR, Boffetta P, Freedland SJ. PMID: 24127391; PMCID: PMC4149056.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    174. Metformin does not affect risk of biochemical recurrence following radical prostatectomy: results from the SEARCH database. Prostate Cancer Prostatic Dis. 2013 Dec; 16(4):391-7. Allott EH, Abern MR, Gerber L, Keto CJ, Aronson WJ, Terris MK, Kane CJ, Amling CL, Cooperberg MR, Moorman PG, Freedland SJ. PMID: 24100644; PMCID: PMC3830588.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    175. Optimization via specific fluorescence brightness of a receptor-targeted probe for optical imaging and positron emission tomography of sentinel lymph nodes. J Biomed Opt. 2013 Oct; 18(10):101315. Qin Z, Hall DJ, Liss MA, Hoh CK, Kane CJ, Wallace AM, Vera DR. PMID: 23958947; PMCID: PMC3745642.
      View in: PubMed   Mentions: 11     Fields:    Translation:Animals
    176. Laparoscopic removal of spermatic cord to reduce incision size of open retroperitoneal lymph node dissection. Urology. 2013 Oct; 82(4):959-62. Woo JR, Liss MA, Kane CJ. PMID: 24074990.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    177. Urology in San Diego--its history in "America's finest city". Urology. 2013 Aug; 82(2):280-3. Cohen SA, Kane CJ, Juwono T, Masterson JH, Kaplan GW. PMID: 23896091.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    178. Do nomograms designed to predict biochemical recurrence (BCR) do a better job of predicting more clinically relevant prostate cancer outcomes than BCR? A report from the SEARCH database group. Urology. 2013 Jul; 82(1):53-8. Teeter AE, Presti JC, Aronson WJ, Terris MK, Kane CJ, Amling CL, Freedland SJ. PMID: 23806388; PMCID: PMC3774016.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    179. Comparison of transrectal and transvaginal hybrid natural orifice transluminal endoscopic surgery partial nephrectomy in the porcine model. Urology. 2013 Jul; 82(1):84-9. Bazzi WM, Stroup SP, Cohen SA, Sisul DM, Liss MA, Masterson JH, Kopp RP, Gudeman SR, Leeflang E, Palazzi KL, Ramamoorthy S, Kane CJ, Horgan S, Derweesh IH. PMID: 23676357.
      View in: PubMed   Mentions: 11     Fields:    Translation:Animals
    180. High serum folate is associated with reduced biochemical recurrence after radical prostatectomy: results from the SEARCH Database. Int Braz J Urol. 2013 May-Jun; 39(3):312-8; discussion 319. Moreira DM, Bañez LL, Presti JC, Aronson WJ, Terris MK, Kane CJ, Amling CL, Freedland SJ. PMID: 23849564.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    181. Prostate cancer: risk versus benefit of lymph node dissection during prostatectomy. Nat Rev Urol. 2013 May; 10(5):262-3. Kane CJ, Liss MA. PMID: 23609844.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    182. Guest editorial: robotic techniques in urologic oncology. World J Urol. 2013 Jun; 31(3):429. Kane CJ, Kader AK. PMID: 23595604.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    183. Editorial comment from Dr Liss and Dr Kane to lymphocele after extraperitoneal robot-assisted radical prostatectomy: a propensity score-matching study. Int J Urol. 2013 Dec; 20(12):1177. Liss MA, Kane CJ. PMID: 23586475.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    184. Multi-institutional validation of the CAPRA-S score to predict disease recurrence and mortality after radical prostatectomy. Eur Urol. 2014 Jun; 65(6):1171-7. Punnen S, Freedland SJ, Presti JC, Aronson WJ, Terris MK, Kane CJ, Amling CL, Carroll PR, Cooperberg MR. PMID: 23587869.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    185. Outcomes and complications of pelvic lymph node dissection during robotic-assisted radical prostatectomy. World J Urol. 2013 Jun; 31(3):481-8. Liss MA, Palazzi K, Stroup SP, Jabaji R, Raheem OA, Kane CJ. PMID: 23512231.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    186. Does timing of cytoreductive nephrectomy impact patient survival with metastatic renal cell carcinoma in the tyrosine kinase inhibitor era? A multi-institutional study. Urology. 2013 Apr; 81(4):805-11. Stroup SP, Raheem OA, Palazzi KL, Liss MA, Mehrazin R, Kopp RP, Patel N, Cohen SA, Park SK, Patterson AL, Kane CJ, Millard F, Derweesh IH. PMID: 23414694.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    187. Commentary on "impact of body mass index on perioperative morbidity, oncological, and functional outcomes after extraperitoneal laparoscopic radical prostatectomy." Campeggi A, Xylinas E, Ploussard G, Ouzaid I, Fabre A, Allory Y, Vordos D, Abbou CC, Salomon L, de la Taille A, Institut National de la Sante et de la Recherche Medicale Unit 955 EQ7, Department of Urology, APHP, CHU Henri Mondor, Créteil, France: Urology 2012;80(3):576-84. Urol Oncol. 2013 Feb; 31(2):274-5. Kane C. PMID: 23465475.
      View in: PubMed   Mentions:    Fields:    
    188. Commentary on "applicability of robot-assisted laparoscopic radical prostatectomy in renal allograft recipients." Wagener N, Nyarangi-Dix JN, Teber D, Zeier M, Hohenfellner M, Department of Urology, University of Heidelberg, Heidelberg, Germany: Transplant Proc 2012; 44(5):1287-92. Urol Oncol. 2013 Feb; 31(2):272. Kane C. PMID: 23465472.
      View in: PubMed   Mentions:    Fields:    
    189. Commentary on "anterior suspension combined with posterior reconstruction during robot-assisted laparoscopic prostatectomy improves early return of urinary continence: A prospective randomized multicentre trial." Hurtes X, Rouprêt M, Vaessen C, Pereira H, d'Arcier BF, Cormier L, Bruyère F, Urology Department, University Hospital of Tours, Tours, France: BJU Int 2012;110(6):875-83. Urol Oncol. 2013 Feb; 31(2):272-3. Kane C. PMID: 23465473.
      View in: PubMed   Mentions:    Fields:    
    190. Commentary on "salvage laparoscopic radical prostatectomy following high-intensity focused ultrasound for treatment of prostate cancer." Leonardo L, Franco G, De Nunzio C, Tubaro A, Salvitti M, Tartaglia N, Simonelli G, De Dominicis C, Department of Urology, La Sapienza University of Rome, Italy: Urology 2012;80(1):130-3. Urol Oncol. 2013 Feb; 31(2):273-4. Kane C. PMID: 23465474.
      View in: PubMed   Mentions:    Fields:    
    191. Commentary on "a matched comparison of perioperative outcomes of a single laparoscopic surgeon versus a multisurgeon robot-assisted cohort for partial nephrectomy." Ellison JS, Montgomery JS, Wolf Jr JS, Hafez KS, Miller DC, Weizer AZ, Department of Urology, University of Michigan, Ann Arbor, MI, USA: J Urol 2012;188(1):45-50. Urol Oncol. 2013 Feb; 31(2):275. Kane C. PMID: 23465477.
      View in: PubMed   Mentions:    Fields:    
    192. Diabetes predicts metastasis after radical prostatectomy in obese men: results from the SEARCH database. BJU Int. 2013 Jun; 111(8):E310-8. Wu C, Aronson WJ, Terris MK, Presti JC, Kane CJ, Amling CL, Freedland SJ. PMID: 23305170.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    193. Detectable prostate-specific antigen Nadir during androgen-deprivation therapy predicts adverse prostate cancer-specific outcomes: results from the SEARCH database. Eur Urol. 2014 Mar; 65(3):620-7. Keto CJ, Aronson WJ, Terris MK, Presti JC, Kane CJ, Amling CL, Freedland SJ. PMID: 23245686; PMCID: PMC3634863.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    194. Delayed radical prostatectomy for intermediate-risk prostate cancer is associated with biochemical recurrence: possible implications for active surveillance from the SEARCH database. Prostate. 2013 Mar; 73(4):409-17. Abern MR, Aronson WJ, Terris MK, Kane CJ, Presti JC, Amling CL, Freedland SJ. PMID: 22996686.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    195. Feasibility of transrectal hybrid natural orifice transluminal endoscopic surgery (NOTES) nephrectomy in the cadaveric model. Urology. 2012 Sep; 80(3):590-5. Bazzi WM, Stroup SP, Cohen SA, Dotai T, Kopp RP, Colangelo C, Raheem OA, Ramamoorthy S, Talamini M, Horgan S, Kane CJ, Derweesh IH. PMID: 22925236.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    196. Obesity, prostate-specific antigen nadir, and biochemical recurrence after radical prostatectomy: biology or technique? Results from the SEARCH database. Eur Urol. 2012 Nov; 62(5):910-6. Ho T, Gerber L, Aronson WJ, Terris MK, Presti JC, Kane CJ, Amling CL, Freedland SJ. PMID: 22921964; PMCID: PMC3500618.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    197. Does radical nephrectomy increase the risk of erectile dysfunction compared with partial nephrectomy? A cohort analysis. BJU Int. 2013 Mar; 111(3 Pt B):E98-102. Kopp RP, Dicks BM, Goldstein I, Mehrazin R, Silberstein JL, Colangelo CJ, Bagrodia A, Bazzi WM, Wake RW, Patterson AL, Kane CJ, Wan JY, Derweesh IH. PMID: 22757628.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    198. A receptor-targeted fluorescent radiopharmaceutical for multireporter sentinel lymph node imaging. Radiology. 2012 Oct; 265(1):186-93. Emerson DK, Limmer KK, Hall DJ, Han SH, Eckelman WC, Kane CJ, Wallace AM, Vera DR. PMID: 22753678; PMCID: PMC3447170.
      View in: PubMed   Mentions: 28     Fields:    Translation:Animals
    199. Robotic prostatectomy improves outcomes--after the potentially risky adoption phase. Oncology (Williston Park). 2012 Jul; 26(7):626, 628, 630. Kane CJ. PMID: 22888562.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    200. Preoperative sentinel lymph node mapping of the prostate using PET/CT fusion imaging and Ga-68-labeled tilmanocept in an animal model. Clin Exp Metastasis. 2012 Oct; 29(7):673-80. Stroup SP, Kane CJ, Farchshchi-Heydari S, James CM, Davis CH, Wallace AM, Hoh CK, Vera DR. PMID: 22714690.
      View in: PubMed   Mentions: 16     Fields:    Translation:Animals
    201. Management of pelvic lymphoceles following robot-assisted laparoscopic radical prostatectomy. Urol Ann. 2012 May; 4(2):111-4. Raheem OA, Bazzi WM, Parsons JK, Kane CJ. PMID: 22629010; PMCID: PMC3355695.
      View in: PubMed   Mentions: 5  
    202. Are repeat prostate biopsies safe? A cohort analysis from the SEARCH database. J Urol. 2012 Jun; 187(6):2056-60. Kopp RP, Stroup SP, Schroeck FR, Freedland SJ, Millard F, Terris MK, Aronson WJ, Presti JC, Amling CL, Kane CJ. PMID: 22498218; PMCID: PMC3409579.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    203. Does salvage radiation therapy change the biology of recurrent prostate cancer based on PSA doubling times? Results from the SEARCH database. Urology. 2012 May; 79(5):1105-10. Muller RL, Presti JC, Aronson WJ, Terris MK, Kane CJ, Amling CL, Freedland SJ. PMID: 22446345; PMCID: PMC3431014.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    204. Effect of race and socioeconomic status on surgical margins and biochemical outcomes in an equal-access health care setting: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. Cancer. 2012 Oct 15; 118(20):4999-5007. Chu DI, Moreira DM, Gerber L, Presti JC, Aronson WJ, Terris MK, Kane CJ, Amling CL, Freedland SJ. PMID: 22415377; PMCID: PMC3376692.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    205. Initial experience with aspirin use during robotic radical prostatectomy. J Laparoendosc Adv Surg Tech A. 2012 Apr; 22(3):225-9. Nowfar S, Kopp R, Palazzi-Churas K, Derweesh IH, Kane CJ. PMID: 22393926.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    206. Obesity is associated with castration-resistant disease and metastasis in men treated with androgen deprivation therapy after radical prostatectomy: results from the SEARCH database. BJU Int. 2012 Aug; 110(4):492-8. Keto CJ, Aronson WJ, Terris MK, Presti JC, Kane CJ, Amling CL, Freedland SJ. PMID: 22094083; PMCID: PMC3343219.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    207. A novel patient-derived intra-femoral xenograft model of bone metastatic prostate cancer that recapitulates mixed osteolytic and osteoblastic lesions. J Transl Med. 2011 Oct 28; 9:185. Raheem O, Kulidjian AA, Wu C, Jeong YB, Yamaguchi T, Smith KM, Goff D, Leu H, Morris SR, Cacalano NA, Masuda K, Jamieson CH, Kane CJ, Jamieson CA. PMID: 22035283; PMCID: PMC3269442.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansAnimalsCells
    208. Robotic-assisted laparoscopic prostatectomy for high-risk prostate cancer: technical considerations and review of the literature. ISRN Urol. 2011; 2011:201408. Stroup SP, Kane CJ. PMID: 22084791; PMCID: PMC3196353.
      View in: PubMed   Mentions: 2  
    209. Comparison of rates and risk factors for development of anaemia and erythropoiesis-stimulating agent utilization after radical or partial nephrectomy. BJU Int. 2012 Apr; 109(7):1019-25. Woldrich J, Mehrazin R, Bazzi WM, Bagrodia A, Kopp RP, Malcolm JB, Kane CJ, Patterson AL, Wan JY, Derweesh IH. PMID: 21933323.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    210. Preoperative weight change and risk of adverse outcome following radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital database. Prostate Cancer Prostatic Dis. 2011 Dec; 14(4):361-6. Whitley BM, Moreira DM, Thomas JA, Aronson WJ, Terris MK, Presti JC, Kane CJ, Amling CL, Freedland SJ, SEARCH Database Study Group. PMID: 21894174.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    211. Serum 25-hydroxyvitamin D and prevention of breast cancer: pooled analysis. Anticancer Res. 2011 Sep; 31(9):2939-48. Mohr SB, Gorham ED, Alcaraz JE, Kane CJ, Macera CA, Parsons JK, Wingard DL, Garland CF. PMID: 21868542.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    212. Partial orchiectomy and testis intratubular germ cell neoplasia: World literature review. Urol Ann. 2011 Sep; 3(3):115-8. Bazzi WM, Raheem OA, Stroup SP, Kane CJ, Derweesh IH, Downs TM. PMID: 21976922; PMCID: PMC3183701.
      View in: PubMed   Mentions: 8  
    213. What do I tell patients about saw palmetto for benign prostatic hyperplasia? Urol Clin North Am. 2011 Aug; 38(3):261-77. Kane CJ, Raheem OA, Bent S, Avins AL. PMID: 21798388.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    214. Comparison of rates and risk factors for development of osteoporosis and fractures after radical or partial nephrectomy. Urology. 2011 Sep; 78(3):614-9. Bagrodia A, Mehrazin R, Bazzi WM, Silberstein J, Malcolm JB, Stroup SP, Raheem O, Wake RW, Kane CJ, Patterson AL, Wan JY, Derweesh IH. PMID: 21777959.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    215. Treatment trends for stage I renal cell carcinoma. J Urol. 2011 Aug; 186(2):394-9. Cooperberg MR, Mallin K, Kane CJ, Carroll PR. PMID: 21679982.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    216. Target localization and toxicity in dose-escalated prostate radiotherapy with image-guided approach using daily planar kilovoltage imaging. Technol Cancer Res Treat. 2011 Feb; 10(1):31-7. Nath SK, Sandhu AP, Sethi RA, Jensen LG, Rosario MD, Kane CJ, Parsons JK, Millard FE, Jiang SB, Rice RK, Pawlicki T, Mundt AJ. PMID: 21214286.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    217. Does PSADT after radical prostatectomy correlate with overall survival?--a report from the SEARCH database group. Urology. 2011 Jan; 77(1):149-53. Teeter AE, Presti JC, Aronson WJ, Terris MK, Kane CJ, Amling CL, Freedland SJ. PMID: 21145094; PMCID: PMC3051841.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    218. Incidence of bladder neck contracture after robot-assisted laparoscopic and open radical prostatectomy. BJU Int. 2010 Dec; 106(11):1734-8. Breyer BN, Davis CB, Cowan JE, Kane CJ, Carroll PR. PMID: 20438567; PMCID: PMC3565608.
      View in: PubMed   Mentions: 43     Fields:    Translation:Humans
    219. Feasibility and efficacy of neoadjuvant sunitinib before nephron-sparing surgery. BJU Int. 2010 Nov; 106(9):1270-6. Silberstein JL, Millard F, Mehrazin R, Kopp R, Bazzi W, DiBlasio CJ, Patterson AL, Downs TM, Yunus F, Kane CJ, Derweesh IH. PMID: 20394613.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    220. Glycemic control and prostate cancer progression: results from the SEARCH database. Prostate. 2010 Oct 01; 70(14):1540-6. Kim HS, Presti JC, Aronson WJ, Terris MK, Kane CJ, Amling CL, Freedland SJ. PMID: 20687228; PMCID: PMC2930134.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    221. Postoperative prostate-specific antigen nadir improves accuracy for predicting biochemical recurrence after radical prostatectomy: Results from the Shared Equal Access Regional Cancer Hospital (SEARCH) and Duke Prostate Center databases. Int J Urol. 2010 Nov; 17(11):914-22. Moreira DM, Presti JC, Aronson WJ, Terris MK, Kane CJ, Amling CL, Sun LL, Moul JW, Freedland SJ. PMID: 20880361; PMCID: PMC3188446.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    222. Robot-assisted laparoscopic radical prostatectomy in men with human immunodeficiency virus. Prostate Cancer Prostatic Dis. 2010 Dec; 13(4):328-32. Silberstein JL, Parsons JK, Palazzi-Churas K, Downs TM, Sakamoto K, Derweesh IH, Woldrich J, Kane CJ. PMID: 20877308.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCellsCTClinical Trials
    223. A natural history of weight change in men with prostate cancer on androgen-deprivation therapy (ADT): results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. BJU Int. 2011 Mar; 107(6):924-8. Kim HS, Moreira DM, Smith MR, Presti JC, Aronson WJ, Terris MK, Kane CJ, Amling CL, Freedland SJ. PMID: 20860651; PMCID: PMC3055926.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    224. Statin medication use and the risk of biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) Database. Cancer. 2010 Jul 15; 116(14):3389-98. Hamilton RJ, Banez LL, Aronson WJ, Terris MK, Platz EA, Kane CJ, Presti JC, Amling CL, Freedland SJ. PMID: 20586112; PMCID: PMC3188453.
      View in: PubMed   Mentions: 54     Fields:    Translation:Humans
    225. Laparo-endoscopic single-site surgery for radical and cytoreductive nephrectomy, renal vein thrombectomy, and partial nephrectomy: a prospective pilot evaluation. Diagn Ther Endosc. 2010; 2010:107482. Derweesh IH, Silberstein JL, Bazzi W, Kopp R, Downs TM, Kane CJ. PMID: 20631830; PMCID: PMC2901611.
      View in: PubMed   Mentions: 5  
    226. Outcomes after radical prostatectomy among men who are candidates for active surveillance: results from the SEARCH database. Urology. 2010 Sep; 76(3):695-700. Kane CJ, Im R, Amling CL, Presti JC, Aronson WJ, Terris MK, Freedland SJ, SEARCH Database Study Group. PMID: 20394969; PMCID: PMC2939285.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansPHPublic Health
    227. Association of cigarette smoking with interval to biochemical recurrence after radical prostatectomy: results from the SEARCH database. Urology. 2010 Nov; 76(5):1218-23. Moreira DM, Antonelli JA, Presti JC, Aronson WJ, Terris MK, Kane CJ, Amling CL, Freedland SJ. PMID: 20381838; PMCID: PMC3177236.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    228. The influence of hepatic function on prostate cancer outcomes after radical prostatectomy. Prostate Cancer Prostatic Dis. 2010 Jun; 13(2):173-7. Bañez LL, Loftis RM, Freedland SJ, Presti JC, Aronson WJ, Amling CL, Kane CJ, Terris MK. PMID: 20195294; PMCID: PMC2947348.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    229. Diabetes and outcomes after radical prostatectomy: are results affected by obesity and race? Results from the shared equal-access regional cancer hospital database. Cancer Epidemiol Biomarkers Prev. 2010 Jan; 19(1):9-17. Jayachandran J, Aronson WJ, Terris MK, Presti JC, Amling CL, Kane CJ, Freedland SJ. PMID: 20056618; PMCID: PMC2805474.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    230. Toxicity analysis of postoperative image-guided intensity-modulated radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2010 Oct 01; 78(2):435-41. Nath SK, Sandhu AP, Rose BS, Simpson DR, Nobiensky PD, Wang JZ, Millard F, Kane CJ, Parsons JK, Mundt AJ. PMID: 19939580.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansPHPublic Health
    231. The effect of race on the discriminatory accuracy of models to predict biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases. Prostate Cancer Prostatic Dis. 2010 Mar; 13(1):87-93. Moreira DM, Presti JC, Aronson WJ, Terris MK, Kane CJ, Amling CL, Sun LL, Moul JW, Freedland SJ. PMID: 19918263; PMCID: PMC3188449.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    232. Obesity as a predictor of adverse outcome across black and white race: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) Database. Cancer. 2009 Nov 15; 115(22):5263-71. Jayachandran J, Bañez LL, Aronson WJ, Terris MK, Presti JC, Amling CL, Kane CJ, Freedland SJ, SEARCH Database Study Group. PMID: 19670453; PMCID: PMC2783966.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    233. Re-calibration and external validation of an existing nomogram to predict aggressive recurrences after radical prostatectomy. BJU Int. 2010 Jun; 105(12):1654-9. Schroeck FR, Kattan MW, Moul JW, Aronson WJ, Presti JC, Terris MK, Kane CJ, Amling CL, Sun L, Freedland SJ. PMID: 19912203; PMCID: PMC7252932.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    234. Definition and preoperative predictors of persistently elevated prostate-specific antigen after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. BJU Int. 2010 Jun; 105(11):1541-7. Moreira DM, Presti JC, Aronson WJ, Terris MK, Kane CJ, Amling CL, Freedland SJ. PMID: 19912191.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    235. Freedom from a detectable ultrasensitive prostate-specific antigen at two years after radical prostatectomy predicts a favorable clinical outcome: analysis of the SEARCH database. Urology. 2010 Feb; 75(2):439-44. Chang SL, Freedland SJ, Terris MK, Aronson WJ, Kane CJ, Amling CL, Presti JC. PMID: 19819536.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    236. Natural history of persistently elevated prostate specific antigen after radical prostatectomy: results from the SEARCH database. J Urol. 2009 Nov; 182(5):2250-5. Moreira DM, Presti JC, Aronson WJ, Terris MK, Kane CJ, Amling CL, Freedland SJ. PMID: 19758614.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    237. Editorial comment. Urology. 2009 Sep; 74(3):617-8. Kane CJ, Dicks B. PMID: 19716915.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    238. Estimated blood loss as a predictor of PSA recurrence after radical prostatectomy: results from the SEARCH database. BJU Int. 2010 Feb; 105(3):347-51. Lloyd JC, Bañez LL, Aronson WJ, Terris MK, Presti JC, Amling CL, Kane CJ, Freedland SJ. PMID: 19709073.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    239. Lymph node dissection during robot-assisted radical prostatectomy: where do we stand? Prostate Cancer Prostatic Dis. 2009; 12(3):227-32. Silberstein JL, Derweesh IH, Kane CJ. PMID: 19546882.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    240. Adequacy of lymphadenectomy among men undergoing robot-assisted laparoscopic radical prostatectomy. BJU Int. 2010 Jan; 105(1):88-92. Cooperberg MR, Kane CJ, Cowan JE, Carroll PR. PMID: 19549119.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    241. Does early prostate-specific antigen doubling time (ePSADT) after radical prostatectomy, calculated using PSA values from the first detectable until the first recurrence value, correlate with standard PSADT? A report from the Shared Equal Access Regional Cancer Hospital Database Group. BJU Int. 2009 Dec; 104(11):1604-9. Teeter AE, Presti JC, Aronson WJ, Terris MK, Kane CJ, Amling CL, Freedland SJ. PMID: 19549124.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    242. Body mass index and prostate specific antigen as predictors of adverse pathology and biochemical recurrence after prostatectomy. J Urol. 2009 Aug; 182(2):491-6; discussion 496-8. Bañez LL, Sun L, Trock BJ, Han M, Partin AW, Aronson WJ, Terris MK, Presti JC, Kane CJ, Amling CL, Moul JW, Freedland SJ. PMID: 19524974.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    243. Predictors of secondary treatment following biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital database. BJU Int. 2010 Jan; 105(1):28-33. Moreira DM, Bañez LL, Presti JC, Aronson WJ, Terris MK, Kane CJ, Amling CL, Freedland SJ. PMID: 19522861.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    244. Validation of a nomogram to predict disease progression following salvage radiotherapy after radical prostatectomy: results from the SEARCH database. BJU Int. 2009 Nov; 104(10):1452-6. Moreira DM, Jayachandran J, Presti JC, Aronson WJ, Terris MK, Kane CJ, Amling CL, Stephenson AJ, Freedland SJ. PMID: 19466946.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    245. Race and time from diagnosis to radical prostatectomy: does equal access mean equal timely access to the operating room?--Results from the SEARCH database. Cancer Epidemiol Biomarkers Prev. 2009 Apr; 18(4):1208-12. Bañez LL, Terris MK, Aronson WJ, Presti JC, Kane CJ, Amling CL, Freedland SJ. PMID: 19336564; PMCID: PMC3179689.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    246. Preoperative predictors of blood loss at the time of radical prostatectomy: results from the SEARCH database. Prostate Cancer Prostatic Dis. 2009; 12(3):264-8. Lloyd JC, Bañez LL, Aronson WJ, Terris MK, Presti JC, Amling CL, Kane CJ, Freedland SJ. PMID: 19322137.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    247. Exposure to Agent Orange is a significant predictor of prostate-specific antigen (PSA)-based recurrence and a rapid PSA doubling time after radical prostatectomy. BJU Int. 2009 May; 103(9):1168-72. Shah SR, Freedland SJ, Aronson WJ, Kane CJ, Presti JC, Amling CL, Terris MK. PMID: 19298411; PMCID: PMC3179688.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic Health
    248. Renal cell carcinoma in the pediatric population: Results from the California Cancer Registry. Pediatr Blood Cancer. 2009 Feb; 52(2):237-41. Silberstein J, Grabowski J, Saltzstein SL, Kane CJ. PMID: 18937317.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    249. Do nomograms predict aggressive recurrence after radical prostatectomy more accurately than biochemical recurrence alone? BJU Int. 2009 Mar; 103(5):603-8. Schroeck FR, Aronson WJ, Presti JC, Terris MK, Kane CJ, Amling CL, Freedland SJ. PMID: 19021608; PMCID: PMC2753544.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    250. What are the factors associated with short prostate specific antigen doubling time after radical prostatectomy? A report from the SEARCH database group. J Urol. 2008 Nov; 180(5):1980-4; discussion 1985. Teeter AE, Bañez LL, Presti JC, Aronson WJ, Terris MK, Kane CJ, Amling CL, Freedland SJ, SEARCH Database Group. PMID: 18801519; PMCID: PMC3182520.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    251. The association between prostate size and Gleason score upgrading depends on the number of biopsy cores obtained: results from the Shared Equal Access Regional Cancer Hospital Database. BJU Int. 2008 Nov; 102(9):1074-9. Turley RS, Terris MK, Kane CJ, Aronson WJ, Presti JC, Amling CL, Freedland SJ, SEARCH Database Study Group. PMID: 18778348; PMCID: PMC3186764.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    252. HIV and prostate cancer: a systematic review of the literature. Prostate Cancer Prostatic Dis. 2009; 12(1):6-12. Silberstein J, Downs T, Lakin C, Kane CJ. PMID: 18711409.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    253. Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases. BJU Int. 2008 Sep; 102(8):969-74. Freedland SJ, Sun L, Kane CJ, Presti JC, Terris MK, Amling CL, Moul JW, Aronson WJ. PMID: 18691175.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    254. Impact of nerve sparing on surgical margins and biochemical recurrence: results from the SEARCH database. Prostate Cancer Prostatic Dis. 2009; 12(2):172-6. Nelles JL, Freedland SJ, Presti JC, Terris MK, Aronson WJ, Amling CL, Kane CJ. PMID: 18626507; PMCID: PMC3174863.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    255. Obesity and positive surgical margins by anatomic location after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital database. BJU Int. 2008 Sep; 102(8):964-8. SEARCH Database Study Group, Jayachandran J, Aronson WJ, Terris MK, Presti JC, Amling CL, Kane CJ, Freedland SJ. PMID: 18691176; PMCID: PMC3175752.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    256. Renal cell cancer stage migration: analysis of the National Cancer Data Base. Cancer. 2008 Jul 01; 113(1):78-83. Kane CJ, Mallin K, Ritchey J, Cooperberg MR, Carroll PR. PMID: 18491376.
      View in: PubMed   Mentions: 203     Fields:    Translation:Humans
    257. Active surveillance for the management of prostate cancer in a contemporary cohort. Cancer. 2008 Jun 15; 112(12):2664-70. Dall'Era MA, Konety BR, Cowan JE, Shinohara K, Stauf F, Cooperberg MR, Meng MV, Kane CJ, Perez N, Master VA, Carroll PR. PMID: 18433013.
      View in: PubMed   Mentions: 123     Fields:    Translation:HumansCTClinical Trials
    258. Decreasing size at diagnosis of stage 1 renal cell carcinoma: analysis from the National Cancer Data Base, 1993 to 2004. J Urol. 2008 Jun; 179(6):2131-5. Cooperberg MR, Mallin K, Ritchey J, Villalta JD, Carroll PR, Kane CJ. PMID: 18423754.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    259. Pelvic lymphadenectomy in prostate cancer. Prostate Cancer Prostatic Dis. 2008; 11(4):320-4. Breyer BN, Greene KL, Dall'Era MA, Davies BJ, Kane CJ. PMID: 18490935.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    260. Watchful waiting versus active surveillance: appropriate patient selection. Curr Urol Rep. 2008 May; 9(3):211-6. Dall'Era MA, Kane CJ. PMID: 18765115.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    261. Prostate cancer stem cell therapy: hype or hope? Prostate Cancer Prostatic Dis. 2008; 11(4):316-9. Masters JR, Kane C, Yamamoto H, Ahmed A. PMID: 18427568.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimals
    262. Sex differences in renal cell cancer presentation and survival: an analysis of the National Cancer Database, 1993-2004. J Urol. 2008 May; 179(5):1709-13; discussion 1713. Woldrich JM, Mallin K, Ritchey J, Carroll PR, Kane CJ. PMID: 18343430.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    263. Risk stratification for biochemical recurrence in men with positive surgical margins or extracapsular disease after radical prostatectomy: results from the SEARCH database. J Urol. 2008 May; 179(5):1791-6; discussion 1796. Jayachandran J, Bañez LL, Levy DE, Aronson WJ, Terris MK, Presti JC, Amling CL, Kane CJ, Freedland SJ, SEARCH Database Study Group. PMID: 18343426; PMCID: PMC3179686.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    264. Limitations of prostate specific antigen doubling time following biochemical recurrence after radical prostatectomy: results from the SEARCH database. J Urol. 2008 May; 179(5):1785-9; discussion 1789-90. Hamilton RJ, Aronson WJ, Terris MK, Kane CJ, Presti JC, Amling CL, Freedland SJ. PMID: 18343434; PMCID: PMC3179690.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    265. A detailed safety assessment of a saw palmetto extract. Complement Ther Med. 2008 Jun; 16(3):147-54. Avins AL, Bent S, Staccone S, Badua E, Padula A, Goldberg H, Neuhaus J, Hudes E, Shinohara K, Kane C. PMID: 18534327; PMCID: PMC2518869.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimals
    266. Effect of BMI on primary treatment of prostate cancer. Urology. 2008 Aug; 72(2):406-11. Davies BJ, Walsh TJ, Ross PL, Knight SJ, Sadetsky N, Carroll PR, Kane CJ. PMID: 18267336.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    267. Small transrectal ultrasound volume predicts clinically significant Gleason score upgrading after radical prostatectomy: results from the SEARCH database. J Urol. 2008 Feb; 179(2):523-7; discussion 527-8. Turley RS, Hamilton RJ, Terris MK, Kane CJ, Aronson WJ, Presti JC, Amling CL, Freedland SJ, SEARCH Database Study Group. PMID: 18076952.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    268. The effect of race/ethnicity on the accuracy of the 2001 Partin Tables for predicting pathologic stage of localized prostate cancer. Urology. 2008 Jan; 71(1):151-5. Heath EI, Kattan MW, Powell IJ, Sakr W, Brand TC, Rybicki BA, Thompson IM, Aronson WJ, Terris MK, Kane CJ, Presti JC, Amling CL, Freedland SJ. PMID: 18242385.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    269. Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer. JAMA. 2007 Nov 21; 298(19):2275-80. Bañez LL, Hamilton RJ, Partin AW, Vollmer RT, Sun L, Rodriguez C, Wang Y, Terris MK, Aronson WJ, Presti JC, Kane CJ, Amling CL, Moul JW, Freedland SJ. PMID: 18029831.
      View in: PubMed   Mentions: 119     Fields:    Translation:Humans
    270. Race, biochemical disease recurrence, and prostate-specific antigen doubling time after radical prostatectomy: results from the SEARCH database. Cancer. 2007 Nov 15; 110(10):2202-9. Hamilton RJ, Aronson WJ, Presti JC, Terris MK, Kane CJ, Amling CL, Freedland SJ. PMID: 17876838.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    271. Effects of hospital procedure volume and resident training on clinical outcomes and resource use in radical retropubic prostatectomy surgery in the Department of Veterans Affairs. J Urol. 2008 Jan; 179(1):272-8; discussion 278-9. Ku TS, Kane CJ, Sen S, Henderson WG, Dudley RA, Cason BA. PMID: 18001784.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    272. Is a positive bladder neck margin truly a T4 lesion in the prostate specific antigen era? Results from the SEARCH Database. J Urol. 2008 Jan; 179(1):124-9; discussion 129. Buschemeyer WC, Hamilton RJ, Aronson WJ, Presti JC, Terris MK, Kane CJ, Amling CL, Freedland SJ. PMID: 17997433.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    273. PSA in the new millennium: a powerful predictor of prostate cancer prognosis and radical prostatectomy outcomes--results from the SEARCH database. Eur Urol. 2008 Apr; 53(4):758-64; discussion 765-6. Freedland SJ, Hotaling JM, Fitzsimons NJ, Presti JC, Kane CJ, Terris MK, Aronson WJ, Amling CL. PMID: 17868976.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    274. Predicting unilateral prostate cancer based on biopsy features: implications for focal ablative therapy--results from the SEARCH database. J Urol. 2007 Oct; 178(4 Pt 1):1249-52. Scales CD, Presti JC, Kane CJ, Terris MK, Aronson WJ, Amling CL, Freedland SJ, SEARCH Database Study Group. PMID: 17698131.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    275. Risk stratification of men with Gleason score 7 to 10 tumors by primary and secondary Gleason score: results from the SEARCH database. Urology. 2007 Aug; 70(2):277-82. Kang DE, Fitzsimons NJ, Presti JC, Kane CJ, Terris MK, Aronson WJ, Amling CL, Freedland SJ, SEARCH Database Study Group. PMID: 17826489; PMCID: PMC3275808.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    276. Body mass index, prostate weight and transrectal ultrasound prostate volume accuracy. J Urol. 2007 Sep; 178(3 Pt 1):990-5. Sajadi KP, Terris MK, Hamilton RJ, Cullen J, Amling CL, Kane CJ, Presti JC, Aronson WJ, Freedland SJ. PMID: 17632170.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    277. Do racial differences in prostate size explain higher serum prostate-specific antigen concentrations among black men? Urology. 2007 Jun; 69(6):1138-42. Mavropoulos JC, Partin AW, Amling CL, Terris MK, Kane CJ, Aronson WJ, Presti JC, Mangold LA, Freedland SJ. PMID: 17572202; PMCID: PMC3275802.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    278. Analysis of complications following partial and total nephrectomy for renal cancer in a population based sample. J Urol. 2007 May; 177(5):1709-14. Joudi FN, Allareddy V, Kane CJ, Konety BR. PMID: 17437791.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansPHPublic Health
    279. Impact of obesity on the utility of preoperative prostate-specific antigen velocity to predict for relapse after prostatectomy: a report from the SEARCH database. Urology. 2007 May; 69(5):921-6. King CR, Freedland SJ, Terris MK, Kane CJ, Amling CL, Aronson WJ, Presti JC. PMID: 17482935.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    280. Education predicts quality of life among men with prostate cancer cared for in the Department of Veterans Affairs: a longitudinal quality of life analysis from CaPSURE. Cancer. 2007 May 01; 109(9):1769-76. Knight SJ, Latini DM, Hart SL, Sadetsky N, Kane CJ, DuChane J, Carroll PR, CaPSURE Investigators. PMID: 17380491.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    281. Optimal timing, cutoff, and method of calculation of preoperative prostate-specific antigen velocity to predict relapse after prostatectomy: a report from SEARCH. Urology. 2007 Apr; 69(4):732-7. King CR, Freedland SJ, Terris MK, Aronson WJ, Kane CJ, Amling CL, Presti JC. PMID: 17445660.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    282. Upgrading and downgrading of prostate needle biopsy specimens: risk factors and clinical implications. Urology. 2007 Mar; 69(3):495-9. Freedland SJ, Kane CJ, Amling CL, Aronson WJ, Terris MK, Presti JC, SEARCH Database Study Group. PMID: 17382152; PMCID: PMC3080253.
      View in: PubMed   Mentions: 62     Fields:    Translation:Humans
    283. Bladder cancer incidence and risk factors in men with prostate cancer: results from Cancer of the Prostate Strategic Urologic Research Endeavor. J Urol. 2007 Mar; 177(3):883-7; discussion 887-8. Boorjian S, Cowan JE, Konety BR, DuChane J, Tewari A, Carroll PR, Kane CJ, Cancer of the Prostate Strategic Urologic Research Endeavor Investigators. PMID: 17296367.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    284. Changing nature of high risk patients undergoing radical prostatectomy. J Urol. 2007 Jan; 177(1):113-7. Kane CJ, Presti JC, Amling CL, Aronson WJ, Terris MK, Freedland SJ, SEARCH Database Study Group. PMID: 17162017.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    285. Health-related quality of life for men with prostate cancer and diabetes: a longitudinal analysis from CaPSURE. Urology. 2006 Dec; 68(6):1242-7. Latini DM, Chan JM, Cowan JE, Arredondo SA, Kane CJ, Penson DF, DuChane J, Carroll PR, CaPSURE Investigators. PMID: 17141841.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    286. Is biopsy Gleason score independently associated with biochemical progression following radical prostatectomy after adjusting for pathological Gleason score? J Urol. 2006 Dec; 176(6 Pt 1):2453-8; discussion 2458. Fitzsimons NJ, Presti JC, Kane CJ, Terris MK, Aronson WJ, Amling CL, Freedland SJ. PMID: 17085127.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    287. Multiinstitutional validation of the UCSF cancer of the prostate risk assessment for prediction of recurrence after radical prostatectomy. Cancer. 2006 Nov 15; 107(10):2384-91. Cooperberg MR, Freedland SJ, Pasta DJ, Elkin EP, Presti JC, Amling CL, Terris MK, Aronson WJ, Kane CJ, Carroll PR. PMID: 17039503.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    288. Clinical and pathologic outcome after radical prostatectomy for prostate cancer patients with a preoperative Gleason sum of 8 to 10. Cancer. 2006 Sep 15; 107(6):1265-72. Bastian PJ, Gonzalgo ML, Aronson WJ, Terris MK, Kane CJ, Amling CL, Presti JC, Mangold LA, Humphreys E, Epstein JI, Partin AW, Freedland SJ. PMID: 16900523.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    289. Laparoscopic versus open cytoreductive nephrectomy in advanced renal-cell carcinoma. J Endourol. 2006 Jul; 20(7):504-8. Eisenberg MS, Meng MV, Master VA, Stoller ML, Rini BI, Carroll PR, Kane CJ. PMID: 16859465.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    290. Laparoscopic approaches to renal malignancies. Curr Probl Cancer. 2006 Jul-Aug; 30(4):168-93. Ross PL, Meng MV, Kane CJ. PMID: 16860165.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    291. The effect of kidney morcellation on operative time, incision complications, and postoperative analgesia after laparoscopic nephrectomy. Int Braz J Urol. 2006 May-Jun; 32(3):273-9; discussion 279-80. Camargo AH, Rubenstein JN, Ershoff BD, Meng MV, Kane CJ, Stoller ML. PMID: 16813669.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    292. Delay of radical prostatectomy and risk of biochemical progression in men with low risk prostate cancer. J Urol. 2006 Apr; 175(4):1298-302; discussion 1302-3. Freedland SJ, Kane CJ, Amling CL, Aronson WJ, Presti JC, Terris MK, SEARCH Database Study Group. PMID: 16515984.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    293. Saw palmetto for benign prostatic hyperplasia. N Engl J Med. 2006 Feb 09; 354(6):557-66. Bent S, Kane C, Shinohara K, Neuhaus J, Hudes ES, Goldberg H, Avins AL. PMID: 16467543.
      View in: PubMed   Mentions: 100     Fields:    Translation:HumansAnimalsCTClinical Trials
    294. Obesity, serum prostate specific antigen and prostate size: implications for prostate cancer detection. J Urol. 2006 Feb; 175(2):500-4; discussion 504. Freedland SJ, Platz EA, Presti JC, Aronson WJ, Amling CL, Kane CJ, Terris MK. PMID: 16406980.
      View in: PubMed   Mentions: 50     Fields:    Translation:Humans
    295. Smoking influences aberrant CpG hypermethylation of multiple genes in human prostate carcinoma. Cancer. 2006 Jan 01; 106(1):79-86. Enokida H, Shiina H, Urakami S, Terashima M, Ogishima T, Li LC, Kawahara M, Nakagawa M, Kane CJ, Carroll PR, Igawa M, Dahiya R. PMID: 16323173.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    296. Prostate biopsy tumor extent but not location predicts recurrence after radical prostatectomy: results from CaPSURE. J Urol. 2006 Jan; 175(1):125-9; discussion 129. Greene KL, Elkin EP, Karapetian A, Duchane J, Carroll PR, Kane CJ, CaPSURE Investigators. PMID: 16406887.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    297. Impact of obesity on prostate cancer recurrence after radical prostatectomy: data from CaPSURE. Urology. 2005 Nov; 66(5):1060-5. Bassett WW, Cooperberg MR, Sadetsky N, Silva S, DuChane J, Pasta DJ, Chan JM, Anast JW, Carroll PR, Kane CJ. PMID: 16286124.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    298. Racial differences in prognostic value of adult height for biochemical progression following radical prostatectomy. Clin Cancer Res. 2005 Nov 01; 11(21):7735-42. Freedland SJ, Aronson WJ, Trock B, Cohen P, Kane CJ, Amling CL, Presti JC, Terris MK, Shared Equal Access Regional Cancer Hospital Database Study Group. PMID: 16278394.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    299. Prostate size and risk of high-grade, advanced prostate cancer and biochemical progression after radical prostatectomy: a search database study. J Clin Oncol. 2005 Oct 20; 23(30):7546-54. Freedland SJ, Isaacs WB, Platz EA, Terris MK, Aronson WJ, Amling CL, Presti JC, Kane CJ. PMID: 16234520.
      View in: PubMed   Mentions: 81     Fields:    Translation:Humans
    300. Promoter CpG hypomethylation and transcription factor EGR1 hyperactivate heparanase expression in bladder cancer. Oncogene. 2005 Oct 13; 24(45):6765-72. Ogishima T, Shiina H, Breault JE, Terashima M, Honda S, Enokida H, Urakami S, Tokizane T, Kawakami T, Ribeiro-Filho LA, Fujime M, Kane CJ, Carroll PR, Igawa M, Dahiya R. PMID: 16007175.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCells
    301. Controversial cases in endourology. J Endourol. 2005 Oct; 19(8):955-8. Wang D, Winfield H, Nakada SY, Kane CJ, L'Esperance JO, Monga M, Kozlowski PM. PMID: 16253057.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    302. Multigene methylation analysis for detection and staging of prostate cancer. Clin Cancer Res. 2005 Sep 15; 11(18):6582-8. Enokida H, Shiina H, Urakami S, Igawa M, Ogishima T, Li LC, Kawahara M, Nakagawa M, Kane CJ, Carroll PR, Dahiya R. PMID: 16166436.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCells
    303. Ethnic group-related differences in CpG hypermethylation of the GSTP1 gene promoter among African-American, Caucasian and Asian patients with prostate cancer. Int J Cancer. 2005 Aug 20; 116(2):174-81. Enokida H, Shiina H, Urakami S, Igawa M, Ogishima T, Pookot D, Li LC, Tabatabai ZL, Kawahara M, Nakagawa M, Kane CJ, Carroll PR, Dahiya R. PMID: 15800905.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCells
    304. Management of isolated renal fossa recurrence following radical nephrectomy. J Urol. 2005 Aug; 174(2):473-7; discussion 477. Master VA, Gottschalk AR, Kane C, Carroll PR. PMID: 16006867.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    305. CpG methylation at promoter site -140 inactivates TGFbeta2 receptor gene in prostate cancer. Cancer. 2005 Jul 01; 104(1):44-52. Zhao H, Shiina H, Greene KL, Li LC, Tanaka Y, Kishi H, Igawa M, Kane CJ, Carroll P, Dahiya R. PMID: 15895377.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    306. Ability of 2 pretreatment risk assessment methods to predict prostate cancer recurrence after radical prostatectomy: data from CaPSURE. J Urol. 2005 Apr; 173(4):1126-31. Mitchell JA, Cooperberg MR, Elkin EP, Lubeck DP, Mehta SS, Kane CJ, Carroll PR. PMID: 15758720.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    307. The impact of obesity on health related quality of life before and after radical prostatectomy (data from CaPSURE). J Urol. 2005 Apr; 173(4):1132-8. Anast JW, Sadetsky N, Pasta DJ, Bassett WW, Latini D, DuChane J, Chan JM, Cooperberg MR, Carroll PR, Kane CJ. PMID: 15758721.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    308. Obesity and prostate cancer clinical risk factors at presentation: data from CaPSURE. J Urol. 2005 Mar; 173(3):732-6. Kane CJ, Bassett WW, Sadetsky N, Silva S, Wallace K, Pasta DJ, Cooperberg MR, Chan JM, Carroll PR. PMID: 15711258.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    309. Methylation of the gamma-catenin gene is associated with poor prognosis of renal cell carcinoma. Clin Cancer Res. 2005 Jan 15; 11(2 Pt 1):557-64. Breault JE, Shiina H, Igawa M, Ribeiro-Filho LA, Deguchi M, Enokida H, Urakami S, Terashima M, Nakagawa M, Kane CJ, Carroll PR, Dahiya R. PMID: 15701841.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    310. Inactivation of the hMSH3 mismatch repair gene in bladder cancer. Biochem Biophys Res Commun. 2004 Dec 17; 325(3):934-42. Kawakami T, Shiina H, Igawa M, Deguchi M, Nakajima K, Ogishima T, Tokizane T, Urakami S, Enokida H, Miura K, Ishii N, Kane CJ, Carroll PR, Dahiya R. PMID: 15541380.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    311. Differences in complications and outcomes for obese patients undergoing laparoscopic radical, partial or simple nephrectomy. J Urol. 2004 Dec; 172(6 Pt 1):2287-91. Anast JW, Stoller ML, Meng MV, Master VA, Mitchell JA, Bassett WW, Kane CJ. PMID: 15538250.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    312. Kidney gene database: a curated and integrated database of genes involved in kidney disease. J Urol. 2004 Dec; 172(6 Pt 1):2344-6. Zhao H, Li LC, Okino ST, Kane CJ, Carroll PR, Dahiya R. PMID: 15538263.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    313. CpG hypermethylation of MDR1 gene contributes to the pathogenesis and progression of human prostate cancer. Cancer Res. 2004 Sep 01; 64(17):5956-62. Enokida H, Shiina H, Igawa M, Ogishima T, Kawakami T, Bassett WW, Anast JW, Li LC, Urakami S, Terashima M, Verma M, Kawahara M, Nakagawa M, Kane CJ, Carroll PR, Dahiya R. PMID: 15342374.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCells
    314. Age-dependent methylation of ESR1 gene in prostate cancer. Biochem Biophys Res Commun. 2004 Aug 20; 321(2):455-61. Li LC, Shiina H, Deguchi M, Zhao H, Okino ST, Kane CJ, Carroll PR, Igawa M, Dahiya R. PMID: 15358197.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    315. Biochemical outcome after radical prostatectomy among men with normal preoperative serum prostate-specific antigen levels. Cancer. 2004 Aug 15; 101(4):748-53. Freedland SJ, Aronson WJ, Kane CJ, Terris MK, Presti JC, Trock B, Amling CL. PMID: 15305405.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    316. The role of transesophageal echocardiography in rapid diagnosis and treatment of migratory tumor embolus. Anesth Analg. 2004 Aug; 99(2):357-9, table of contents. Chen H, Ng V, Kane CJ, Russell IA. PMID: 15271705.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    317. Obesity and biochemical outcome following radical prostatectomy for organ confined disease with negative surgical margins. J Urol. 2004 Aug; 172(2):520-4. Freedland SJ, Terris MK, Presti JC, Amling CL, Kane CJ, Trock B, Aronson WJ, Search Database Study Group. PMID: 15247719.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    318. Obstructive lower urinary tract symptoms correlate with erectile dysfunction. Urology. 2004 Jun; 63(6):1148-52. Elliott SP, Gulati M, Pasta DJ, Spitalny GM, Kane CJ, Yee R, Lue TF. PMID: 15183969.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    319. Preoperative model for predicting prostate specific antigen recurrence after radical prostatectomy using percent of biopsy tissue with cancer, biopsy Gleason grade and serum prostate specific antigen. J Urol. 2004 Jun; 171(6 Pt 1):2215-20. Freedland SJ, Terris MK, Csathy GS, Kane CJ, Amling CL, Presti JC, Dorey F, Aronson WJ, Search Database Study Group. PMID: 15126788.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    320. Update of staging and risk assessment for prostate cancer patients. Curr Opin Urol. 2004 May; 14(3):163-70. Hittelman AB, Purohit RS, Kane CJ. PMID: 15069307.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    321. Predictors of prostate-specific antigen progression among men with seminal vesicle invasion at the time of radical prostatectomy. Cancer. 2004 Apr 15; 100(8):1633-8. Freedland SJ, Aronson WJ, Presti JC, Amling CL, Terris MK, Trock B, Kane CJ. PMID: 15073850.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    322. Do younger men have better biochemical outcomes after radical prostatectomy? Urology. 2004 Mar; 63(3):518-22. Freedland SJ, Presti JC, Kane CJ, Aronson WJ, Terris MK, Dorey F, Amling CL, SEARCH Database Study Group. PMID: 15028449.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    323. Laparoscopic partial nephrectomy with temporary arterial occlusion: description of technique and renal functional outcomes. Urology. 2004 Feb; 63(2):241-6. Kane CJ, Mitchell JA, Meng MV, Anast J, Carroll PR, Stoller ML. PMID: 14972462.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    324. Palliative transurethral prostate resection for bladder outlet obstruction in patients with locally advanced prostate cancer. J Urol. 2004 Feb; 171(2 Pt 1):668-71. Crain DS, Amling CL, Kane CJ. PMID: 14713783.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    325. Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group. J Clin Oncol. 2004 Feb 01; 22(3):446-53. Freedland SJ, Aronson WJ, Kane CJ, Presti JC, Amling CL, Elashoff D, Terris MK. PMID: 14691122.
      View in: PubMed   Mentions: 104     Fields:    Translation:Humans
    326. The percentage of prostate needle biopsy cores with carcinoma from the more involved side of the biopsy as a predictor of prostate specific antigen recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. Cancer. 2003 Dec 01; 98(11):2344-50. Freedland SJ, Aronson WJ, Terris MK, Kane CJ, Amling CL, Dorey F, Presti JC. PMID: 14635068.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    327. Impact of patient educational level on treatment for patients with prostate cancer: data from CaPSURE. Urology. 2003 Dec; 62(6):1035-9. Kane CJ, Lubeck DP, Knight SJ, Spitalny M, Downs TM, Grossfeld GD, Pasta DJ, Mehta SS, Carroll PR. PMID: 14665350.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    328. Health related quality of life patterns in patients treated with interstitial prostate brachytherapy for localized prostate cancer--data from CaPSURE. J Urol. 2003 Nov; 170(5):1822-7. Downs TM, Sadetsky N, Pasta DJ, Grossfeld GD, Kane CJ, Mehta SS, Carroll PR, Lubeck DP. PMID: 14532784.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansPHPublic Health
    329. Sociodemographic and clinical risk characteristics of patients with prostate cancer within the Veterans Affairs health care system: data from CaPSURE. J Urol. 2003 Sep; 170(3):905-8. Cooperberg M, Lubeck DP, Penson D, Mehta SS, Carroll PR, Kane CJ. PMID: 12913727.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    330. The human T-cell factor-4 gene splicing isoforms, Wnt signal pathway, and apoptosis in renal cell carcinoma. Clin Cancer Res. 2003 Jun; 9(6):2121-32. Shiina H, Igawa M, Breault J, Ribeiro-Filho L, Pookot D, Urakami S, Terashima M, Deguchi M, Yamanaka M, Shirai M, Kaneuchi M, Kane CJ, Dahiya R. PMID: 12796377.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCells
    331. Should a positive surgical margin following radical prostatectomy be pathological stage T2 or T3? Results from the SEARCH database. J Urol. 2003 Jun; 169(6):2142-6. Freedland SJ, Aronson W, Presti JC, Kane CJ, Terris MK, Elashoff D, Amling CL, SEARCH Database Study Group. PMID: 12771736.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    332. Percent of prostate needle biopsy cores with cancer is significant independent predictor of prostate specific antigen recurrence following radical prostatectomy: results from SEARCH database. J Urol. 2003 Jun; 169(6):2136-41. Freedland SJ, Aronson WJ, Terris MK, Kane CJ, Amling CL, Dorey F, Presti JC, SEARCH Database Study Group. PMID: 12771735.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    333. Improved clinical staging system combining biopsy laterality and TNM stage for men with T1c and T2 prostate cancer: results from the SEARCH database. J Urol. 2003 Jun; 169(6):2129-35. Freedland SJ, Presti JC, Terris MK, Kane CJ, Aronson WJ, Dorey F, Amling CL, SEARCH Database Study Group. PMID: 12771734.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    334. Erdheim-Chester disease: case report and review of associated urological, radiological and histological features. J Urol. 2003 Apr; 169(4):1470-1. Yun EJ, Yeh BM, Yabes AP, Coakley FV, Kane CJ. PMID: 12629387.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    335. Comparison of percentage of total prostate needle biopsy tissue with cancer to percentage of cores with cancer for predicting PSA recurrence after radical prostatectomy: results from the SEARCH database. Urology. 2003 Apr; 61(4):742-7. Freedland SJ, Aronson WJ, Csathy GS, Kane CJ, Amling CL, Presti JC, Dorey F, Terris MK, SEARCH Database Study Group. PMID: 12670558.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    336. Time trends in biochemical recurrence after radical prostatectomy: results of the SEARCH database. Urology. 2003 Apr; 61(4):736-41. Freedland SJ, Presti JC, Amling CL, Kane CJ, Aronson WJ, Dorey F, Terris MK, SEARCH Database Study Group. PMID: 12670557.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    337. Effect of age on biochemical disease-free outcome in patients with T1-T3 prostate cancer treated with definitive radiotherapy in an equal-access health care system: a radiation oncology report of the Department of Defense Center for Prostate Disease Research. Int J Radiat Oncol Biol Phys. 2003 Mar 15; 55(4):964-9. Johnstone PA, Riffenburgh RH, Moul JW, Sun L, Wu H, McLeod DG, Kane CJ, Martin DD, Kusuda L, Lance R, Douglas R, Donahue T, Beat MG, Foley J, Chung A, Soderdahl D, Do J, Amling CL, Department of Defense Center for Prostate Disease Research. PMID: 12605974.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    338. Comparison of preoperative prostate specific antigen density and prostate specific antigen for predicting recurrence after radical prostatectomy: results from the search data base. J Urol. 2003 Mar; 169(3):969-73. Freedland SJ, Kane CJ, Presti JC, Terris MK, Amling CL, Dorey F, Aronson WJ. PMID: 12576824.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    339. Using the percentage of biopsy cores positive for cancer, pretreatment PSA, and highest biopsy Gleason sum to predict pathologic stage after radical prostatectomy: the Center for Prostate Disease Research nomograms. Urology. 2003 Mar; 61(3):589-95. Gancarczyk KJ, Wu H, McLeod DG, Kane C, Kusuda L, Lance R, Herring J, Foley J, Baldwin D, Bishoff JT, Soderdahl D, Moul JW. PMID: 12639653.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    340. Limited value of bone scintigraphy and computed tomography in assessing biochemical failure after radical prostatectomy. Urology. 2003 Mar; 61(3):607-11. Kane CJ, Amling CL, Johnstone PA, Pak N, Lance RS, Thrasher JB, Foley JP, Riffenburgh RH, Moul JW. PMID: 12639656.
      View in: PubMed   Mentions: 82     Fields:    Translation:Humans
    341. PGDB: a curated and integrated database of genes related to the prostate. Nucleic Acids Res. 2003 Jan 01; 31(1):291-3. Li LC, Zhao H, Shiina H, Kane CJ, Dahiya R. PMID: 12520005; PMCID: PMC165455.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    342. Is there a difference in outcome after radical prostatectomy between patients with biopsy Gleason sums 4, 5, and 6? Results from the SEARCH database. Prostate Cancer Prostatic Dis. 2003; 6(3):261-5. Freedland SJ, Amling CL, Terris MK, Presti JC, Aronson WJ, Elashoff D, Kane CJ, SEARCH Database Study Group. PMID: 12970733.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    343. Prospective comparison of computerized tomography and excretory urography in the initial evaluation of asymptomatic microhematuria. J Urol. 2002 Dec; 168(6):2457-60. Gray Sears CL, Ward JF, Sears ST, Puckett MF, Kane CJ, Amling CL. PMID: 12441939.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    344. Beta-catenin mutations correlate with over expression of C-myc and cyclin D1 Genes in bladder cancer. J Urol. 2002 Nov; 168(5):2220-6. Shiina H, Igawa M, Shigeno K, Terashima M, Deguchi M, Yamanaka M, Ribeiro-Filho L, Kane CJ, Dahiya R. PMID: 12394763.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    345. Initiation of salvage therapy for prostate cancer. Prostate Cancer Prostatic Dis. 2002; 5(2):136-43. Johnstone PA, Booth R, Riffenburgh RH, Amling CL, Kane CJ, Moul JW. PMID: 12497004.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    346. Relationship between obesity and race in predicting adverse pathologic variables in patients undergoing radical prostatectomy. Urology. 2001 Nov; 58(5):723-8. Amling CL, Kane CJ, Riffenburgh RH, Ward JF, Roberts JL, Lance RS, Friedrichs PA, Moul JW. PMID: 11711349.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    347. Intraoperative cell salvage in radical retropubic prostatectomy. Urology. 2001 Nov; 58(5):740-5. Gray CL, Amling CL, Polston GR, Powell CR, Kane CJ. PMID: 11711352.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    348. Critical roles of a cyclic AMP responsive element and an E-box in regulation of mouse renin gene expression. J Biol Chem. 2001 Dec 07; 276(49):45530-8. Pan L, Black TA, Shi Q, Jones CA, Petrovic N, Loudon J, Kane C, Sigmund CD, Gross KW. PMID: 11564732.
      View in: PubMed   Mentions: 48     Fields:    Translation:AnimalsCells
    349. Screening for subclinical stenosis in native vessel arteriovenous fistulae. J Am Soc Nephrol. 2001 Aug; 12(8):1729-1733. Tonelli M, Jindal K, Hirsch D, Taylor S, Kane C, Henbrey S. PMID: 11461946.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansPHPublic Health
    350. A comparison of radical retropubic with perineal prostatectomy for localized prostate cancer within the Uniformed Services Urology Research Group. BJU Int. 2001 Jan; 87(1):61-5. Lance RS, Freidrichs PA, Kane C, Powell CR, Pulos E, Moul JW, McLeod DG, Cornum RL. PMID: 11121994.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    351. Impact of socioeconomic status and race on clinical parameters of patients undergoing radical prostatectomy in an equal access health care system. Urology. 2000 Dec 20; 56(6):1016-20. Tarman GJ, Kane CJ, Moul JW, Thrasher JB, Foley JP, Wilhite D, Riffenburgh RH, Amling CL. PMID: 11113750.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    352. Prostate cancer in men age 50 years or younger: a review of the Department of Defense Center for Prostate Disease Research multicenter prostate cancer database. J Urol. 2000 Dec; 164(6):1964-7. Smith CV, Bauer JJ, Connelly RR, Seay T, Kane C, Foley J, Thrasher JB, Kusuda L, Moul JW. PMID: 11061892.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    353. Current management of severely encrusted ureteral stents with a large associated stone burden. J Urol. 2000 Sep; 164(3 Pt 1):648-50. Borboroglu PG, Kane CJ. PMID: 10953117.
      View in: PubMed   Mentions: 43     Fields:    Translation:Humans
    354. Impact of body weight on urinary electrolytes in urinary stone formers. Urology. 2000 Jun; 55(6):825-30. Powell CR, Stoller ML, Schwartz BF, Kane C, Gentle DL, Bruce JE, Leslie SW. PMID: 10840085.
      View in: PubMed   Mentions: 60     Fields:    Translation:Humans
    355. Sildenafil citrate-associated priapism. Urology. 2000 Jun 01; 55(6):950. Sur RL, Kane CJ. PMID: 10840123.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    356. Unenhanced helical computed tomography in the evaluation of acute flank pain. Curr Opin Urol. 2000 Mar; 10(2):123-9. Miller OF, Kane CJ. PMID: 10785854.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    357. Drug-seeking behavior in urolithiasis in the noncontrast computed tomography era: 2 cases. Urology. 1999 Oct; 54(4):744. Gray CL, Kane CJ. PMID: 10754147.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    358. Immediate and postoperative complications of transurethral prostatectomy in the 1990s. J Urol. 1999 Oct; 162(4):1307-10. Borboroglu PG, Kane CJ, Ward JF, Roberts JL, Sands JP. PMID: 10492185.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    359. Time to stone passage for observed ureteral calculi: a guide for patient education. J Urol. 1999 Sep; 162(3 Pt 1):688-90; discussion 690-1. Miller OF, Kane CJ. PMID: 10458343.
      View in: PubMed   Mentions: 106     Fields:    Translation:Humans
    360. Re: Metastatic adenocarcinoma of the prostate to the choroid with loss of visual acuity as a presenting symptom. J Urol. 1999 Sep; 162(3 Pt 1):809. Kane CJ. PMID: 10458385.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    361. Holmium:YAG laser lithotripsy of intrahepatic biliary calculi. J Endourol. 1999 Jun; 13(5):381-3. Tarman GJ, Lenert JT, Hall L, Kane CJ. PMID: 10446802.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    362. Care provision and community adjustment of rural consumers with serious mental illness. Arch Psychiatr Nurs. 1999 Feb; 13(1):19-29. Kane C, Blank M, Hundley P. PMID: 10069099.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    363. Free-to-total prostate-specific antigen ratios 18-24 months following external beam radiation for adenocarcinoma of the prostate. J Surg Oncol. 1999 Feb; 70(2):91-4. Ward JF, Johnstone PA, Kane CJ. PMID: 10084650.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    364. Prospective comparison of unenhanced spiral computed tomography and intravenous urogram in the evaluation of acute flank pain. Urology. 1998 Dec; 52(6):982-7. Miller OF, Rineer SK, Reichard SR, Buckley RG, Donovan MS, Graham IR, Goff WB, Kane CJ. PMID: 9836541.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCTClinical Trials
    365. The prevalence of measles antibody in human immunodeficiency virus-infected patients in northern California. J Infect Dis. 1998 Oct; 178(4):1177-80. Kemper CA, Gangar M, Arias G, Kane C, Deresinski SC. PMID: 9806055.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    366. Keratinizing desquamative squamous metaplasia of the kidney mimicking transitional cell carcinoma. Urology. 1998 Sep; 52(3):512-3. Boswell PD, Fugitt B, Kane CJ. PMID: 9730474.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    367. Testicular infarction associated with sickle cell disease. J Urol. 1998 Jul; 160(1):130. Holmes NM, Kane CJ. PMID: 9628625.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    368. Second primary malignancies in T1-3N0 prostate cancer patients treated with radiation therapy with 10-year followup. J Urol. 1998 Mar; 159(3):946-9. Johnstone PA, Powell CR, Riffenburgh R, Rohde DC, Kane CJ. PMID: 9474189.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    369. The fate of 10-year clinically recurrence-free survivors after definitive radiotherapy for T1-3N0M0 prostate cancer. Radiat Oncol Investig. 1998; 6(2):103-8. Johnstone PA, Powell CR, Riffenburgh R, Bethel KJ, Kane CJ. PMID: 9572687.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    370. Renal tubular acidosis. Urology. 1997 Aug; 50(2):279. Holmes NM, Kane CJ, Cilento BG. PMID: 9255303.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    371. Yield of imaging and scintigraphy assessing biochemical failure in prostate cancer patients. Urol Oncol. 1997 Jul-Aug; 3(4):108-12. Johnstone PA, Tarman GJ, Riffenburgh R, Rohde DC, Puckett ML, Kane CJ. PMID: 21227114.
      View in: PubMed   Mentions: 10     Fields:    
    372. Renal imaging with spiral CT scan: clinical applications. Tech Urol. 1997; 3(4):202-8. Holmes NM, McBroom S, Puckett ML, Kane CJ. PMID: 9531103.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    373. Travels with HIV: the compliance and health of HIV-infected adults who travel. Int J STD AIDS. 1997 Jan; 8(1):44-9. Kemper CA, Linett A, Kane C, Deresinski SC. PMID: 9043981.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    374. Role of proximal promoter elements in regulation of renin gene transcription. J Biol Chem. 1996 Sep 13; 271(37):22499-505. Petrovic N, Black TA, Fabian JR, Kane C, Jones CA, Loudon JA, Abonia JP, Sigmund CD, Gross KW. PMID: 8798416.
      View in: PubMed   Mentions: 21     Fields:    Translation:AnimalsCells
    375. Ultrasonographic appearance of necrotizing gangrene: aid in early diagnosis. Urology. 1996 Jul; 48(1):142-4. Kane CJ, Nash P, McAninch JW. PMID: 8693639.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    376. Sequential granulocyte colony-stimulating factor increases cisplatin cytotoxicity in human epithelial ovarian cancer cell lines. Gynecol Oncol. 1996 Mar; 60(3):450-3. Fanning J, Hilgers RD, Kane C, Medrano C. PMID: 8774656.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    377. Voiding dysfunction in human immunodeficiency virus infections. J Urol. 1996 Feb; 155(2):523-6. Kane CJ, Bolton DM, Connolly JA, Tanagho EA. PMID: 8558651.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    378. Adenocarcinoma of the prostate metastatic to the choroid of the eye. Prostate. 1995 Dec; 27(6):336-9. Keizur JJ, Kane CJ, North R, Leidich RB. PMID: 7501546.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    379. Current indications for open stone surgery in an endourology center. Urology. 1995 Feb; 45(2):218-21. Kane CJ, Bolton DM, Stoller ML. PMID: 7855969.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    380. Transient bacteremia due to Mycobacterium avium complex in patients with AIDS. J Infect Dis. 1994 Aug; 170(2):488-93. Kemper CA, Havlir D, Bartok AE, Kane C, Camp B, Lane N, Deresinski SC. PMID: 8035044.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    381. Family management of schizophrenia: a comparison of behavioral and supportive family treatment. Psychiatr Q. 1992; 63(2):159-86. Zastowny TR, Lehman AF, Cole RE, Kane C. PMID: 1488460.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    382. Direct evidence for spatial and temporal regulation of transforming growth factor beta 1 expression during cutaneous wound healing. J Cell Physiol. 1991 Jul; 148(1):157-73. Kane CJ, Hebda PA, Mansbridge JN, Hanawalt PC. PMID: 1907288.
      View in: PubMed   Mentions: 68     Fields:    Translation:HumansAnimals
    383. Isolation and characterization of renin-expressing cell lines from transgenic mice containing a renin-promoter viral oncogene fusion construct. J Biol Chem. 1990 Nov 15; 265(32):19916-22. Sigmund CD, Okuyama K, Ingelfinger J, Jones CA, Mullins JJ, Kane C, Kim U, Wu CZ, Kenny L, Rustum Y, et al. PMID: 2174057.
      View in: PubMed   Mentions: 38     Fields:    Translation:AnimalsCells
    384. Transforming growth factor-beta 1 localization in normal and psoriatic epidermal keratinocytes in situ. J Cell Physiol. 1990 Jul; 144(1):144-50. Kane CJ, Knapp AM, Mansbridge JN, Hanawalt PC. PMID: 1694857.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    385. Identification of a transcriptional nuclear regulatory protein which exhibits specificity for expression of adult genes. Trans Assoc Am Physicians. 1990; 103:258-62. Paslidis NJ, Wedrychowski A, Romine M, Sims SS, Seong D, Howard OM, Wu KC, Kane CJ, Yuan TY, Deisseroth AB. PMID: 2132536.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    386. 5' region of zeta-globin and GMCSF genes share binding site for nuclear proteins. Trans Assoc Am Physicians. 1988; 101:180-4. Howard OM, Kane C, Deisseroth A. PMID: 3077728.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    387. Treatment of bronchial asthma with cromolyn. JAMA. 1969 Sep 22; 209(12):1881-3. Williams MH, Kane C. PMID: 4896497.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    With one click, see people who:

    Mentor Faculty

    Run Clinical Trials

    See more options in the Advanced Search tab

    Christopher's Networks
    Concepts (760)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (133)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (59)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSD Profiles is managed by the UC San Diego Altman Clinical and Translational Research Institute (ACTRI).
    This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California